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INTRODUCfION 
In patients with congenital diaphragmatic hernia (CDH) a defect in the diaphragm exists 
together with a variable amount of pulmonary hypoplasia. After birth the defect in the 
diaphragm is corrected by removing the herniated viscera from the chest and closure of 
the diaphragm. The estimated incidence is 1 in 2000 to 3000 newborns [1,2,3]. 
There are several types of herniation, named according to the position of the defect: 
posterolateral hernia with or without a sac (Bochdalek type), parasternal hernia through 
the foramen of Morgagni, central hernia and eventration of the diaphragm. The 
Bochdalek type accounts for 85% of all congenital diaphragmatic hernias [1]. Left-sided 
posterolateral defects occur eight times more frequently than right-sided defects [3]. 
Serious clinical symptoms, most of them due to pulmonary hypoplasia, occur shortly after 
birth and, the current, mortality rate range from 40-70% [4,5]. This mortality rate has 
not dropped dramatically, in disappointing contrast to the enormous efforts (prenatal 
diagnosis, a variety of vasoactive drugs, improved ventilatory methods) that have been 
made to surmount the pulmonary problems [4,5]. 
CDH is universally seen with pulmonary hypoplasia and/or pulmonary hypertension; this 
results in the clinical picture of respiratory distress and right-to-left shunting that 
disconcert so many intensivists fighting for the lives of these newhorns. 
The management of a newborn with (prenatally) diagnosed CDH depends highly on the 
understanding of the natural history, and pathophysiology, together with a study of 
(manipulative) prognostic factors that could affect the outcome. 
Therefore, the use of animal models is an indispensable necessity in research on CDH. 
Up to now, there is little detailed knowledge about the etiology and pathogenesis 
involved in the closing process of the diaphragm and its relationship with lung 
development. The influence of drugs or hormones on this mechanism also remains 
obscure. An animal model provides opportunities to study the progress of postnatal 
complications and their underlying basis. 
In this thesis the use of an animal model for the study of congenital diaphragmatic 
hernia is described [6]. This model is based on the early induction of CDH in fetal rats 
by using 2,4-dichlorophenyl-p-nitrophenyl ether (nitrofen); this compound was originally 
used as a herbicide [7,8]. 
The objectives of this thesis are to: 
1. Compare the induced CDH in rats with the human situation and other available 
animal models. 
2. Describe the morphological characteristics of the developing rat lung and 
diaphragm in congenital diaphragmatic hernia compared with controls. 
3. Evaluate the suitability of this model in testing different ventilatory modes and 
the subsequent reaction of the CDH lung from a biochemical and histological 
point of view. 
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These goals are addressed in chapters 3 to 9; the epilogue (chapter 10) discusses the 
benefits of this model compared to the other models used; future aspects in CDH 
research and the possible role of the rat model are also discussed. 
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LITERATURE REVIEW 
2.1 History of congenital diaphragmatic hernia 
Bonetus described congenital diaphragmatic hernia in an anatomical tome in 1679 [1]. 
In 1848 Bochdalek gave an accurate description of herniation of the bowel through the 
posterior part of the diaphragm, the posterolateral defect has from that time borne his 
name [2]. Heidenhain performed the first diaphragmatic hernia operation in a 9-year-old 
boy in 1902 [3]. The patient even survived the first World War as a frontline soldier and 
showed good health on physical examination in 1920 [4]. 
Greenwald and Steiner's report on a group of 82 children with a diaphragmatic defect 
(1929) showed that, out of 11 patients who were operated, oniy 6 recovered. However, 
these survivors were over 7 montbs of age at operation and the hernias were described 
as oesophageal [5]. They considered presentation of the hernia immediately after birth 
as lethal, and that: "little or nothing can be done from a surgical standpoint". 
Ladd and Gross (1940) recommended emergency surgery after their first successful 
operation of a Bochdalek hernia in children [6] and newborns [7]; in 1953 they reported 
a mortality of 8 patients in a series of 63 infants and children. All but six of these 
patients were older than 24 hours when operated [8]. 
The availability of endotracheal intubation and ventilatory assistance did not provide the 
success that was expected. Research was aimed at the pulmonary complications 
encountered; Campanale and Rowland (1955) described the presence of pulmonary 
hypoplasia and a reduction in the number and differentiation of alveolar ducts and 
alveoli [9]. 
Despite the obtained experience in CDH treatment and research since this time, the 
overall mortality of CDH "stabilized" between 30·60% [10,11]; these figures are 
disappointing in comparison with the results obtained in the surgical treatment of other 
major congenital anomalies. 
2.2 Diagnosis and clinical situation 
CDH can be detected in utero by (routine) antenatal ultrasonography. Herniated 
abdominal viscera and or stomach can be seen in the chest; a mediastioal shift can also 
he detected in some patients [12]. 
Solitary CDH can not be detected at a chromosomal level; the use of diagnostic methods 
in this field has not led to an early detection of CDH. CDH can be part of major 
congenital syndromes like Apert [13], Cornelia de Lange, Fryns [14], and Pierre Robin 
[15] or a chromosomal defect as trisomy 18 or trisomy 21 [16,17]; the prognosis in cases 
with associated major congenital anomalies is poor [17]. 
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Familial occurrence of congenital diaphragmatic hernia was first described in 1916 by 
Makela [18).Since then, scattered reports indicating the occurrence in siblings, twins, and 
in two generations of the same family appeared [19-21). None of these reports provided 
a definite explanation of the pattern of inheritance, but multifactorial inheritance was the 
most probable way [22,23). 
The diagnosis CDH has to be differentiated from cystic adenomatoid malformation of 
the lung and other cystic masses in the mediastinum. The diagnosis of other simultaneous 
occurring anatomical abnormalities (cardiac, urogenital or cranial malformations) by a 
specialised radiologist can determine the optimal postnatal policy [24,25). It allows 
maternal transport to a specialized centre, planned delivery and immediate resuscitation. 
However, in the majority of cases, the afflicted infant is born without suspicion of a 
congenital diaphragmatic hernia and develops respiratory distress within a variable time 
after the first breath. The abdomen fails to develop the normal protuberance as air is 
swallowed and remains scaphoid; the anteroposterior diameter of the chest may increase 
as the bowel distends with air. Breath sounds are absent on the ipsilateral side, and 
occasionally bowel sounds may be heard in the chest. The apical heartbeat is displaced 
to the side opposite the diaphragmatic defect. The infant has increasing tachypnea, 
cyanosis, and retraction and may rapidly die from respiratory failure. Air-filled intestinal 
loops on chest roentgenogram establish the diagnosis in most patients; usually, only a 
small portion of lung is visible in the upper part of the chest with displacement of the 
heart to the opposite side. 
While most patients develop symptoms in the first hours of life, the diagnosis may be 
delayed for days, weeks and sometimes years [4,26). In general, the later the onset of 
symptoms, the better the prognosis. Postoperative survival approaches 100% for infants 
who were not brought to operation until after the first 24-48 hours [27). 
With the improvement of intensive care, also the recognition of the mechanisms involved 
in CDH enlarged. Much of the early published literature about persistent fetal 
circulation (PFC) or persistent pulmonary hypertension of the newborn (PPHN), is not 
written about infants with congenital diaphragmatic hernia, but its applicability to this 
condition is well documented [28,29). The neonatal hypoxemia due to pulmonary 
hypertension, and the subsequent right-to-left shunting of unsaturated blood through the 
foramen ovale and ductus arteriosus was described by Naeye and Letts in newborns [30) 
and CDH [31). Kitagawa et al. [32) examined in detail the lungs of a child with CDH and 
found a reduced number of alveoli, together with pathological, excessive muscularization 
of pre-acinar arteries. Using similar techniques, Hislop and Reid [33) found that the 
degree of hypoplasia in the ipsilateral and contralateral lungs was different at birth and 
this difference was maintained until death in a 2-month-old baby following correction of 
CDH. 
Until 1986 it was normal pediatric surgical practice to treat patients with CDH as an 
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emergency condition [27]: evacuation of the viscera out of the thoracic cavity would 
reasonably improve the ventilatory situation. Many newborns in poor clinical condition, 
due to a combination of hypothermia, asphyxia and low systemic tension were operated. 
Postoperatively three groups were recognised; in the first group patients improved and 
survived, in the second group patients improved only temporarily (the so· called 
honeymoon period) but died later, and the third group consisted of patients who showed 
no improvement at all [34]. In the 1980s, several centres observed the beneficial effect 
of preoperative stabilization and subsequent delayed surgery in the overall survival 
[10,35]. 
The improvement in preoperative stabilization was possible because of the use of new 
ventilatory techniques as High Frequency Oscillation (HFO), and Extra Corporeal 
Membrane Oxygenation (ECMO) [36·38]. Also surfactant replacement [39,40] therapy 
is reported to improve the oxygenation and reduce the peak pressures needed. The most 
enigmatic part in CDH treatment consists of the puhnonary hypertension strategy; 
nitroglycerine (NTG) and nitroprusside, effective in cardiac-related pulmonary 
hypertension, failed in many patients. TIle same is true for other drugs, as the serotonin 
antagonist Ketenserin, prostacyclin [41], MgCI, [42], and prostaglandin E2 [43]. The 
reason for this failure is the substantial lack of knowledge on the mechanisms involved 
in the development of pulmonary hypertension in congenital diaphragmatic hernia. 
Research is now aimed at this problem, and the establishment of the effectiveness of 
nitric oxide [44] and the endothelium derived relaxing factor (EDRF) [45] on regulation 
of the puhnonary vascular tone is promising. 
2.3 The lung: Normal development in humans 
The development of the human lung is described by several authors; two of them offered 
an important, generally accepted standard in the research of lung development. The first, 
Reid [46,47], described lung development by three laws that offer a framework to 
interpret and diagnose the nature of disturbed growth and its timing. 
Law I 
The bronchial tree is developed by the 16th week 
Law II 
Alveoli develop after birth, increasing in number until the age of 8 years and in size until 
growth of the chest wall finishes with adulthood. 
Law III 
The pre-acinar vessels (arteries and veins) follow the development of the airways, the 
intra-acinar that of the alveoli. Muscularization of the intra-acinar arteries does not keep 
pace with the appearance of new arteries. 
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The second author, Burri [48] followed a more histological approach in his description 
of the five stages in lung development. 
Embryonic stage 
The lung begins to develop during stage 12 of development (about 26 days) and is first 
indicated by a median laryngotracheal groove in the caudal end of the ventral wall of the 
pharynx. The endodermal lining of the laryngotracheal groove gives rise to the 
epithelium and glands of the larynx, trachea, and bronchi and to the pulmonary lining 
epithelium. The connective tissue, cartilage, and smooth muscle of these structures 
develop from the splanchnic mesenchyme located ventral to the foregut. 
Pseudoglandular period (5 - 17 weeks) 
In this stage the developing lung somewhat resembles a gland. The tubules in the lung 
tissue are lined by epithelium composed of columnar or approximately cuboidal cells 
surrounded by mesenchyme. This period is marked by a continuous growth and branching 
process in which epithelio-mesenchymal interactions playa determining role in regulating 
this process. 'Finally, all major pre-acinar elements of the lung have formed, the vessels 
induded, in a pattern corresponding to that of adult age. 
Canalicular period (17 - 26 weeks) 
This period is characterized by the occurrence of tubules lined by cuboidal epithelium 
and situated close to the capillary system. By 24 weeks, each terminal bronchiole has 
given rise to two or more respiratory bronchioles. The mesenchymal tissue thins out, and 
capillary invasion into these peripheral units is also seen. 
Saccular or terminal sac period (24 weeks to birth) 
This final developmental stage before birth is characterized by a further thinning of the 
interstitium and a flattening of most of the epithelium to give a close link between 
capillaries and epithelial cells. The saccules have a relatively large lumen and rather 
smooth walls and form clusters. 
Alveolar or postnatal period 
This final stage, formation of true alveoli, occurs postnatally. It is marked by the 
occurrence of distinct pouches in the smooth walled saccules. The lining of these pouches 
is composed of great and small alveolar cells. 
Connecting Reid's laws and the stages mentioned by Burri makes it possible to 
determine in which stage of lung development a possible derailment took place. 
In general, with adaptation of the time axis, the same sequence of developmental stages 
are found in other mammals. Pringle [49] expressed the various phases of lung 
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development as percentage of the elapsed pregnancy enabling him to compare lung 
development in different species. 
2.4 Pulmonary vascular development 
Angiogenesis is first detected in the coats of the developing trachea, esophagus and lung 
buds at stage 14 (about 32 days after fertilisation). A vascular plexus forms that receives 
its blood supply both from branches of the aortic sac as well as from numerous branches 
of the dorsal aorta, the intersegmental arteries [50]. By the end of the 5th week of 
gestation the primitive pulmonary arteries become incorporated into the sixth aortic arch 
and the intersegmental arteries involute. Connections with systemic arteries may persist 
abnormally. 
Reid's third law states that the pre-acinar vessels (both arteries and veins) develop at the 
same time as the airways, so that by the 16th week all pre-acinar artery branches are 
present [51]. 
The structure of the pulmonary artery varies with the size of the vessel and also the 
developmental stage of the lung. The muscular coat of the arteries begins to develop 
during the canalicular stage [51]. The axial arteries from hilum to the 7th generation are 
elastic; beyond this point they are muscular, partial muscular or, at the level of the intra-
acinar artery, predominantly non-muscular. By definition, an elastic artery has more than 
five elastic laminae in its media, a muscular between two and five. A partially muscular 
artery has muscle in only part of its circumference; at this level the completely muscular 
coat has been replaced by a spiral. A non-muscular artery is similar in structure to an 
alveolar capillary, but is of a larger diameter. 
The smallest muscular and probably also the partially muscular artery represent the 
resistance arteries. This muscularisation decreases towards the periphery. In·the newborn 
there is one artery for every 20 alveoli; this ratio is reduced to 8: 1 in the adult due to 
formation of new alveoli postnatally [46,47,52,53]. 
Two types of pulmonary arteries are distinguished: the conventional type that accompany 
airways branching from the axial airway, and additional or supernumerary arteries which 
are lateral branches of the conventional arteries that directly supply the peribronchial 
parenchyma [46,47,51]. The second type are considerably more numerous than the 
conventional branches, although their diameter is at any level smaller than that of the 
conventional arteries. TIleY contribute in a significant way to the cross-section of the 
totally recruited vascular bed. Branching becomes more frequent towards the periphery. 
At pre-acinar level the supernumerary arteries contribute about 25% of the cross-
sectional area of the side branches, whereas at the intra-acinar level they make up 33% 
[54]. In the normal lung, according to Hislop and Reid [47,51,53] there are usually 23 
generations of conventional arteries along the posterior basal artery and 64 
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supernumerary branches. It has been suggested that, in the normal lung, the 
supernumerary arteries facilitate blood oxygenation by allowing passage of venous blood 
to the more remote alveoli adjacent to large arteries, veins, and airways [55]. 
2.5 Development of the diaphragm 
The development of the diaphragm, a musculotendinous separation between the thoracic 
and abdominal cavity, is described in two parts: first the development of the 
diaphragmatic primordium and second the closure of the pleuro-peritoneal canals [56]. 
At the end of the third week of gestation a mass of mesoderm cranial to the pericardial 
cavity is identifiable as the beginning of the septum transversum. The ingrowth of liver 
cells into the septum transversum causes it to expand in a ventro-Iateral direction. The 
septum transversum is continuous with the dorsal structures of the emhryo via the 
pulmonary ridges laterally and the gastrohepatic ligament dorsally. The formed pleuro-
peritoneal' canals are surrounded by the septum transversum (ventral), the 
pleuroperitoneal membrane (lateral) and the tissues of the mediastinum (medio-dorsal). 
Due to enlargement and subsequent burrowing of the pleural cavities in the lateral body 
walls (9th to 12th week) the body wall (costal) part is incorporated into the diaphragm 
external to the portions derived from the pleuro-peritoneal membranes [57-60]. 
Embryology in humans is difficult to comprehend by means of an accidentally obtained 
postmortem piece, because embryology is a continuous changing ongoing process. The 
use of animals to study embryology is an obvious choice, provided that the conclusions 
drawn from such animal study is also applicable to the human situation. 
Iritani [61] recognized in mice a posthepatic mesenchymal plate (PHMP) as origin for 
the most muscular part of the diaphragm. Other authors considered the PHMP as a part 
of the septum transversum. 
2.6 Closure of the pleuroperitoneal canals 
The mechanisms responsible for the closure of the pleuroperitoneal canals is thought to 
playa major role in the development of congenital diaphragmatic hernia. However there 
is ongoing discussion between the several investigators about the mechanisms that lead 
to closure of the developing diaphragm. 
1) The growth of the pleuro-peritoneal membrane leads to the closure of the canal 
[60,62]. 
2) The dorsocranial development of the liver is the decisive factor in the closing process 
which takes place at membranous level [57]. 
3) The suprarenal glands are especially important for the closure of the canals [58]. 
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4) The continuous growth and pressure of all the organs in this region (liver,suprarenal 
gland) forced the canal to close [59]. 
5) The caudal and lateral growth of the PHMP leads to closure of the diaphragm [61]. 
6) Kluth et a!. [56] used scanning electron microscopy in rat fetuses, and remarked that 
the closure of the pleuroperitoneal canals took place in two layers. First, the nnderlying 
organs approach each other closely and second, the canal is closed at a membranous 
level by folds derived from the pleural serosae of the liver, the suprarenal gland and the 
pleuroperitoneal membrane. The closing process is more rapid on the right side than on 
the left. 
2.7 Abnormal lung development 
Developmental defects of the lung include: 1) agenesis or hypoplasia of both lungs, one 
lung, or single lobes; 2) tracheal and bronchial anomalies; 3) vascular anomalies; and 4) 
congenital cysts. 
Pulmonary hypoplasia in newborns is a known accompaniment of a number of 
malformation syndromes. It is diagnosed in 7.8 to 10.9% of neonatal necropsies and in 
about 50% of the necropsied neonates with congenital anomalies [63-65]. Factors that 
influence human lung growth unfavourably include amount of intrathoracic space (CDH, 
cysts) [32,66] and amniotic space (oligohydramnios due to rupture of the membranes or 
Potter syndrome) [66-68], and decreased pulmonary arterial flow in cardiovascular 
malformations like tetralogy of Fallot or hypoplastic right heart [69,70]. 
A working definition of pulmonary hypoplasia was estahlished by retrospective 
assessment of lung growth both in recognized and hypothetical pulmonary hypoplasia-
associated conditions; pulmonary weight with reference to total body weight was a 
parameter by which cases of pulmonary hypoplasia were selected [67;71]. Several 
investigators [66,72,73] also performed a radial alveolar count of the distal airways to 
characterize these affected lungs further. Radial alveolar count was described in detail 
by Emery and Mithal [74]: From the centre of a respiratory bronchiolus a perpendicular 
line is dropped on to the nearest and definite connective tissue septum. The number of 
alveoli cut by this line was then counted. Pulmonary hypoplasia can be found in 
congenital diaphragmatic hernia [9,32,65,66], anencephalus [66,75], anuric renal 
anomalies with oligohydramnios [76,77], and skeletal anomalies restricting thoracic 
volume [78]. There is, however, a spectrum of severity of pulmonary hypoplasia, often 
proportional to the severity of the underlying condition. The normal lung weights or 
LW IBW ratios in different series are reported between 0.18 and 0.22 [66,76]; Emery and 
Mithal excluded the lung with edema and exudate and found a mean LW IBW ratio of 
0.13 [74]. Wet lung weight may be a poor measure of tissue mass for the perinatal lung 
as it is affected by the quantity of lung liquid retained within the airways and interstitial 
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tissue. The radial alveolar count provides a clearer definition between pulmonary 
hypoplasia and normal subjects than the LW IBW ratio alone [73]. 
Other criteria to describe lung growth and maturation are quantitative biochemical assays 
as used by Wigglesworth. He found that one of the major problems in studying 
pulmonary hypoplasia is the difficulty of establishing criteria for the diagnosis of 
hypoplastic lungs at necropsy in babies who may vary widely both in gestational age and 
in weight for gestation. 
DNA measurement as an index of cell population is widely accepted [79]. Wigglesworth 
and Desai [80] found that total lung DNA near term in many cases of pulmonary 
hypoplasia was similar to that in normal fetuses at about 20 weeks gestation. He 
concluded the lung growth must have been impaired at some time before 20 weeks and 
divided patients with puhnonary hypoplasia into two groups. 
The first group consists of fetus with oligohydramnios due to either renal agenesis, 
urethral obstruction or amniotic fluid leakage in early pregnancy without other 
malformations. The lungs in this group have the same characteristic histological pattern 
with narrow airways and impaired maturation of respiratory epithelium, associated with 
lack of interstitial tissue and failure of normal elastic tissue development around the 
airways and terminal sacs [79]. 
The second group (including CDH) has a normal or increased volume of amniotic fluid. 
In this group the lungs, although small, are of appropriate maturity for gestational age, 
with normal epithelial maturation, normal phospholipid content, and normai elastin 
development. However, Wigglesworth and Desai also suspected a relation between 
growth and maturation, which was indicated by the hypoplastic left lung associated with 
left-sided CDH in which there is retarded biochemical maturation compared with greater 
maturity of the right lung [79,80,81]. Lung growth and maturation during the early fetal 
period is critically dependent on influences outside the lung [82], such as fetal breathing 
movements and lung liquid secretion. These influences were already described in 1941 
by Potter and Bohlender [83] in their review article; they also emphasized the need for 
animal research. 
2.8 Pulmonary vascular abnormalities 
Another major clinical problem in the newborn is persistent fetal circulation or persistent 
pulmonary hypertension of the neonate (PPHN). It is characterized by right-to-left 
shunting through the ductus arteriosus and foramen ovale. This may be associated with 
a multitude of other conditions such as persistent ductus arteriosus, pulmonary 
hypoplasia and meconium aspiration [28,84,85]. 
To compare the possible differences in pulmonary artery structure, a standardised way 
of evaluating these vessels is necessary. Hislop and Davies [51,52] described a way to 
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process lung tissue into histological slides resulting in barium-gelatin filled arteries, dark 
stained elastin layers easy to distinguish from the surrounding, but empty lung veins. In 
these slides, external diameter, wall thickness, wall structure (muscular, partially 
muscular, or non-muscular) is registered for each artery, as is the type of the 
accompanying airway. The percentage wall thickness (2x wall thickness/external 
diameter) is calculated [51]. In addition, the use of a radiopacque injection medium 
allows rapid assessment of the pulmonary circulation through arteriograms [46]. 
In the normal newborn the alveolar region is virtually free of muscular arteries; in case 
of puhnonary hypertension there is extension of the muscularised arteries to this alveolar 
region [51,54,55]. Reduction in the number of arteries will reduce cross-section as does 
narrowing of the arterial lumen, so the number of arteries in relation to parenchymal 
structures is also estimated. 
Morphometric studies have established differences in artery structure hetween congenital 
diaphragmatic hernia [32], rhesus isoimmunisation [86] and renal agenesis [87]. 
Geggel and Reid [88] distinguished between maladaption, maldevelopment, and under 
development. Maladaption represents a structurally normal lung at birth save that 
increase in compliance of small resistance arteries had not occurred. The pulmonary 
vascular bed is highly reactive and in a vicious circle of acidosis, hypoxia, hypercarbia and 
pUlmonary vasoconstriction pulmonary hypertension may develop. 
Maldevelopment indicates the new and precocious muscularisation seen in idiopathic 
persistent pulmonary hypertension. Causes of this excessive muscularization are 
hypoplastic left heart syndrome, chronic intra-uterine hypoxia and also meconium 
aspiration [47]. 
Underdevelopment represents the reduced size of arteries seen in congenital anomalies 
associated with puhnonary hypoplasia, such as CDH, renal agenesis or dysplasia, 
oligohydramnios. 
Cause 
Excessive muscularization 
PPHN - idiopathic 
Meconium aspiration-fatal 
TAPVC-SD 
TAPVC-ID 
Coarctation, VSD. PDA 
Underdevelopment 
CDR 
Renal agenesis/dysplasia 
Rhesus isoimmunization 
Idiopathic (primary) 
Mruadaption 
VSD 
Airway 
Number of Number of 
bronchial alveoli per 
generations acinus 
N N 
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Abbreviations: CDH = congenital diaphragmatic hernia, ID = inJradiaphragmatic. PDA = patem ductus aneriosis, PPHN = 
persistent pulmonary hypertension o/the newborn, SD = supradiaphragmatic, TAPVC ;::: total anomalous pulmonary verwus 
connection, VSD = ventricular septal defeer, N = normal, NA = 1U)t available. t = increase, ~ = decrease. 
Notes: 1, dependent on the severity of coarctation; 2. preacinar arteries; 3, small/or age but approprialejor lung 
volume; 4, small/or age but large/or lung volume; 5, preacinar medial hypertrophy. 
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Intra-acinar arteries in the healthy newborns are virtually all non-muscular, however in 
persistent pulmonary hypertension of the newborn or persistent fetal circulation, most 
of them are completely muscularized. Geggel et at. [34] gave a detailed morphometric 
analysis of the lungs in a series of 7 infants with CDH. He divided these patients in two 
groups; 4 infants who were never able to be adequately ventilated (the no-honeymoon 
group), and 3 who did well initially following repair of their diaphragmatic hernia, but 
then developed an increased pulmonary vascular resistance and died (honeymoon group). 
No-honeymoon patients have smaller lungs, increased muscularization of intra-acinar 
arteries, and decreased luminal area of pre-acinar and intra-acinar diameter. They 
concluded that the clinical deterioration in the honeymoon group depends on a 
vasoconstrictive response in the hypoplastic vascular bed. Persistent hypoxemia in the no-
honeymoon group is determined by the severity of pulmonary hypoplasia and by the 
structural remodelling of the pulmonary arteries. 
Studying lungs of CDH patients, Kitagawa et at. [32] first pointed out that there were 
abnormalities in both the numbers of arterial branches and their muscularisation. They 
reported that the number of conventional branches was reduced to 14 in the right lung 
and to 12 in the left lung. A reduction of supernumerary branches to 17 in the right lung, 
but to only 36 in the left lung was observed. They also described thicker muscular walls 
in smaller diameter arteries (shift to the left); see Fig 1. 
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Figure 1. Distributioll, ill diameter groups, of the muscular, partially muscular, alld 11011-
muscular arteries ill the 1I0nllai lIelVbom IUllg alld ill the left 10IVer lobe of a case of 
cOllgellital diaphragmatic hemia_ III the latter each stlllctural type is foulld in smaller arteries 
thall is nonllal. (Published lVith penllissioll of the author [32j) 
Naeye et aI., Levin, and Nakamura et al. reported uniform thickening of the pulmonary 
artery muscle mass in their study of congenital diaphragmatic hernia lungs [31,89,90]. 
Resistance within the pulmonary circulation drops either because of vasodilatation or by 
recruitment of arteries [91,92]. The pulmonary artery bed is a low pressure system, 
considerable increase in flow, as in exercise, is possible without increase in pressure 
because a large proportion of the arteries is unused at rest and available for recruitment. 
Vasoconstriction produces an acute rise in pressure or resistance by functional narrowing; 
in chronic pulmonary hypertension there has to be other, structural changes. Stenmark 
et al. [92] attempted to integrate the sequence of events starting with the physical stress 
and ending ~th the restructured vessel; they distinguished an early and late (chronic) 
state suggesting an analogous mechanism in pulmonary remodelling as found in systemic 
hypertension induced vascular diseases. 
The exact mechanisms that control the normal resting tone in the pulmonary circulation 
and their reactivity are not known [91,92]. The presence of smooth muscle cells and 
connective tissue elements in the wall must be taken into account, but these are 
influenced by a lot of mediators (e.g. bradykinin, angiotensin II, epinephrine, 
thromboxane B2, and metabolites of arachidonic acid) in a very complex, until yet 
unrevealed, cascade [92]. 
2.9 Possible mechanisms in the pathogenesis of CDH 
Since the mechanism of normal diaphragm development is unknown, there will also be 
much speculation about the pathogenesis of CDH. In the past, several theories had been 
proposed to explain the occurrence of postero-Iateral diaphragmatic defects which 
include [93]: 
1) defects caused by improper development of the pleuro-peritoneal membrane [60,62]. 
2) failure of muscularisation of the lumbocostal trigone and pleuro-peritoneal canal 
[62,94]. 
3) permeation of bowel through the postero-Iateral part of the diaphragm (foramen of 
Bochdalek) [58]. 
4) Early return of the intestines into the abdominal cavity with a still open canal [62,94]. 
5) Abnormal persistence of the lung in the pleuroperitoneal canal might prevent closure 
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of the canal [95J. 
6) Abnormal development of the embryonic lung and posthepatic mesenchyme causes 
non-closure of pleuro-peritoneal canals [61J. 
The most common cited theory is the one describing failure of the pleuro-peritoneal 
membrane to meet the septum transversum. However, Wells [59J thought the 
disappearance of the pleuroperitoneal canals is caused by the development of the 
underlying organs. He presumed that non-closure of the canal leads to herniation of the 
gut; he was not able to render a mechanism for his idea. 
The theory of a weak spot in the diaphragm through which the bowel loops are pushed 
in the thoracic cavity causing pulmonary hypoplasia (point 1-4) has to be considered as 
well [94J. 
Little is known about the intra-abdominal pressure in the developing embryo; it is 
unlikely that the gut returns in the abdominal cavity against a positive abdominal 
pressure. 1bis return occurs in a relative late stage of lung and diaphragm development 
[94J. 
2.10 Lung development in different species 
Developmental stages of the normal human lung can also be recognized in animals. 
However, there are important differences between species regarding the various stages 
of lung development, especially when they are considered in terms of percentage of the 
total gestational period. 
Figures 2a-d show the outline of fetal lung development in humans, monkey, sheep, 
rabbits, and rats as they were published by Pringle [49J. 
According to Pringle [49J,three important facts in the study of lung develbpment have 
to be considered. 
First within any species, at any stage of development, there is considerable variation in 
lung development from fetus to fetus. This makes it impossible to draw sharp boundaries 
between phases of lung development. 
Second, in different areas within one lung, there is often considerable variation of lung 
development. One part of the lung may develop ahead of, or behind, other parts of the 
lung. 
Third, there is considerable variation between species in the proportion of gestation 
occupied by the various phases in lung development. This species variation is most 
marked in the pseudoglandular and alveolar phases of development. This fact makes 
direct comparison of lung development between species invalid when it is only based on 
percentage of gestation. Such comparisons can only be made after determining the exact 
phase of development and a note of the time of gestation in days or weeks and 
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Figure 2 (reprint with pennissian[49j). Schematic amline of lung development in various 
species. Fig 2a. Human lung. Nate the overlap between the phases. The pseudaglandular 
phase extends to about 20 weeks (50% gestation). The alveolar phase is clearly established 
by 36 weeks [90% gestation}, although many areas of the itlllg are stm in the saccular phase 
beyond tenn. Fig 2b. Sheep lung. The pseudaglandular phase extends to 85-90 days (about 
60% gestation). The canalicular and saccular phases are foreshortened, but the alveolar 
phase is clearly established by 125 days (86% gestation) a stage in gestation vel)' similar to 
the first appearance of alveoli in the human lung. Fig 2e. Rabbit lung. The pseudoglandular 
phase extends to 23-24 days (75% gestation). Alveoli appear just before birth. Fig 2d. Rat 
lung. The pseudaglandular phase occupies 86% of gestation. The saccular phase does not 
begin until the day before birth (95% gestation) and true alveoli do nat begin to develop 
until 4 days after birth. 
percentage of gestation. 
Ten Have investigated fetal lung development in mice by using inununocytochemical and 
ultrastructural techniques; this led to a new concept of lung development [96]. 
Starting at gestational day 9.5, the lung buds give rise to a branching tubular system 
called the primordial system; this is lined by undifferentiated columnar (primordial) 
epithelium. 
Differentiation of the primordial system into bronchial (COlumnar) and respiratory 
(cuboid) system starts around day 14.2 [97]. Immunocytochemistry and electron 
microscopy detect a sharp demarcation between respiratory (alveolar) system and 
bronchial epithelium [97,98]. This sharp demarcation supports the view [98] that the 
bronchial and respiratory systems originate from a separate part of the primordial 
system. 
The cuboid epithelium is composed of type II (precursor) cells. Type II cell is an 
indicator for all the morphological expressions of this cell; it plays a key role in the 
pulmonary acinus formation being the stem cell of the complete alveolar epithelium 
(type I and II cells). It has also, as the only dividing cell, a primary morphogenetic 
function in pulmonary acinus formation [96,97]. 
Comparative studies have shown that this concept on mouse lung development is also 
true for the rat [99] and humans [100]. 
2.11 Experimental models of CDH 
The wide variety in clinical manifestation and the persisting disappointing results in 
treating CDH resulted in a demand for a model in which the encountered problems 
could be studied. 
Harrison et al. defined in 1980 several characteristics which are necessary to develop 
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such an animal model [101]: 
1. The model must simulate CDH in human infants. 
2. The model must allow simulated correction of the diaphragmatic hernia by removal 
of the space occupying lesion during gestation. 
3. The model must perrnit quantitative assessment of the effect of the simulated lesion 
and its correction on survival at birth and on pulmonary parenchymal and pulmonary 
vascular development. 
Experimental production of CDH in pregnant animals was reported by DeLorimer et al. 
[102] in 1967 and Kent et at. in 1972 [103]. TIley used pregnant ewes and created 
diaphragmatic hernias in the fetal Iambs. Petal surgery was performed, finally leading to 
an opening of the left hemithorax at the eight interspace. The lung was retracted and a 
hole, 1 em in diameter, was made in the diaphragm through which a loop of small bowel 
was pulled in the chest. Kent used four fetuses of 69 - 72 days gestation and studied 
ventilation, hemodynamics and resulting pathologic processes at term to relate them to 
the effects of CDH in neonates. He concluded that the earlier in fetal life the lesion was 
produced the more severe the hypoplasia. He measured higher mean pulmonary pressure 
after deliveiy in CDH animals; no significant differences were found in cardiac output. 
In 1977 Ohi et at. [104] reported creation of CDH in fetal rabbits; these animals were 
subjected to partial excision of the left diaphragm in utero at a gestational age of 23-26 
days. He concluded that the so-called hypoplastic lung in diaphragmatic hernia is small 
in size but potentially functioning when relieved of compression. Matsuda et al. advanced 
the operating age to 21-25 days in order to create the defect in the pseudoglandular 
phase of lung development [105]. They performed histological measurements of the 
pulmonary vasculature and concluded that developmental pulmonary vascular disorders 
caused by diaphragmatic hernia result in the absolute reduction of the pulmonary 
vascular capacity probably causing pulmonary hypertension and ppc. 
In 1980 Harrison et at. [101] introduced a conical, silicone-rubber balloon in the left 
hemithorax of fetal lambs, which was progressively inflated over the last trimester to 
simulate the compression by growing viscera. They considered that if the pulmonary 
hypoplasia is a developmental consequence of compression by the herniated viscera, 
removal of this space-occupying lesion in utero may allow pulmonary development 
proceed normally. Thus correcting CDH in utero may allow the lung to develop 
sufficiently to support life at birth. 
Harrison's group "corrected" congenital diaphragmatic hernia intra-uterine by deflation 
of the balloon [106]; this allowed sufficient lung growth and development to alleviate 
respiratory insufficiency and to assure survival of the lambs delivered by cesarian section. 
The correction resulted in a significant increase in lung weight, air capacity, compliance, 
and area of the pulmonary vascular bed [106]. 
The balloon model could not be used to study the feasibility of correction nor to develop 
the surgical techniques necessary for actual successful surgical repair. Therefore, 
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Harrison et al. [107] created CDH by making a hole in the left diaphragm and 
demonstrated that herniated viscera produced pulmonary hypoplasia comparable to that 
produced by the balloon. Intra-uterine correction of CDH was performed [107]. Adzick 
et al. advanced the creation of CDH to 60-63 days gestation [108]; a phase in fetal lamb 
lung development [109] that corresponds with appearance of CDH in the human 
situation (8-10 weeks gestation). 
The fetus with CDH shows many similarities to the premature, surfactant deficient 
newborn with respiratory distress syndrome (RDS), considering histological, 
morphological, and quantitative biochemical criteria [65,80]. Pringle et al. [110] studied 
pulmonary maturity and morphology in CDH lambs at various stages of gestation with 
electronmicroscopy. They found an increase in number and size of the type II 
pneumocyte; these changes affected the ipsilateral greater than the contralateral lung, 
and these changes were partially reversed by in utero repair. However, in this study no 
type II pneumocyte function studies or surfactant analyses were performed. 
Glick et al. [111] hypothesized that a surfactant deficiency may partly contribute to the 
pathophysiology of CDH. In term CDH lambs, they found surfactant deficiency with 
associated decreased compliance. The phospholipid concentrations, as well as the 
phospholipid composition (decreased phosphatidylcholine (PC)), were significantly 
changed. 
Puhnonary hypoplasia is also encountered in congenital malformations other than CDH 
such as renal dysplasia [76,77]. This pulmonary hypoplasia can be produced 
experimentally in fetal rats [112] by amniocentesis, or in fetal lambs by bladder outlet 
obstruction [113]. These experiments suggest a relationship between pulmonary fluid 
dynamics and pulmonary growth [113-115]. In 1984 Adzick et al. demonstrated that 
tracheal ligation in fetal lambs could prevent pulmonary hypoplasia associated with 
oligohydramnios [116]. This study was recently repeated and extended. Wilson et al. [117] 
divided 95 gestational day sheep in nephrectomy, nephrectomy + tracheal ligation (TL), 
tracheal ligation alone and sham operated controls. DiFiore et al. [118] performed 
diaphragmatic hernia and TL in 90 days gestation sheep. 
They concluded: TL in the fetus accelerated lung growth beyond normal limits, even in 
the absence of fetal kidneys. Lung growth was achieved, at least in part, by cell 
proliferation rather than hypertrophy. They also found histologically relatively normal 
lung parenchyma, suggesting that developmental pathways are not markedly disordered 
by tracheal ligation. Fetal TLproduces increased intratracheal pressure [118], which may 
be responsible for the pulmonary growth observed. Their suggestion that it could also 
prevent pulmonary hypoplasia in CDH provided the lungs were ligated in an early phase 
of development was confirmed by Hedrick et al. [119]. They created CDH in lambs at 
75 days gestation and ligated the trachea at 120 days. After delivery at 135-140 days 
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tracheal ligation or plugging the upper airway in CDH lambs reduces the abdominal 
viscera from the chest, accelerates lung growth and improves oxygenation and ventilation 
at birth. This plugging may provide a less invasive way of intra-uterine CDH treatment. 
2.12 CDH in mice and rats 
Iritani postulated in 1984 that an abnormality in the development of the lung is 
responsible for the diaphragmatic defect [61]. He nsed pregnant mice; 2,500 ppm 2,4-
dichloro-4'-nitrodiphenyl ether (nitrofen) was given in the food from the 5th gestational 
day until the day of sacrifice (days 9-18). Hypoplasia of the lung buds may affect the 
later growth of the lung itself and cause abnormality in the vascular system of both lungs, 
resulting in persistent fetal circulation [61]. 
The fetal rat model of diaphragmatic hernia [120] which is described in this thesis is 
derived from the results of Iritani and data of other toxicological studies with Nitrofen 
in rats. 
2.13 Phar~acology of nitrofen (2,4-dichloro-4'-nitrodiphenyl ether) 
Originally, nitrofen is a selective pre and early post-emergence herbicide for the control 
of annual grasses and weeds on a variety of food crops. Nitrofen (or commercially 
offered under the name of Tok®) is the common name adopted by the Weed Society of 
America. The Rohm and Haas Company obtained the first registration in 1966 [121]. 
Almost 20 years of commercial nitrofen use has not produced indications of toxicity in 
man, with the exception of occasional reports of skin irritation. In adult rats and mice, 
oral LD,o values range from 2.4 to 3.6 g/kg [122]; death in these animals from acute 
exposure generally occurs within 2-8 days preceded by progressive depression of all vital 
functions. 
The teratogenic properties of nitrofen have been investigated in some 25 studies 
conducted in several laboratories utilizing different strains and 4 species of laboratory 
animals [122]. In these studies, the identified LOEL (lowest observable effect level) was 
0.15 mg/kg/day for production of malformations with oral treatment on days 5-17 of 
gestation in the rat. Comparison of this value to oral LD,o values in rats indicates that 
the compound is a potent and selective teratogen in rodents. This raises concern about 
the tertogenicity of other diphenyl ethers, which constitute a major class of pre- and post-
emergent herbicides that also includes bifenox, acifluoren, oxyfluoren and CNP. Diphenyl 
ethers are also being used industrially as components of heat transfer media, solvents and 
plasticizers. 
In a series of experiments with rats Costlow and Manson [123-125] showed day 11 of 
gestation to be the most sensitive day for induction of neonatal mortality; oral 
administration of 116 mg/kg nitrofen to the dam on this day was the LD,o for the 
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neonate. The malformations in the neonates observed were dose related: 70 mg/kg 
produced hydronephrosis and a slightly delay in ossification. Similarly, doses of 115 
mg/kg and higher produced diaphragmatic hernia in term fetuses, and doses over 150 
mg/kg decreased body weight gain and produced heart malformations (ventricular septal 
defect, double outlet right ventricle and transposition of the great vessels). 
No increases in chromosomal abberations were found in bone marrow taken from 
animals killed at approximately 6, 24 and 48 h after a single dose of nitrofen or 6 h after 
the last of the multiple exposures [126]. 
Pharmacokinetic studies in non-pregnant rats revealed that within 48 h following the last 
dose of 125 mg/kg [14C]nitrofen 72 - 100% of the radioactivity was excreted, with 14-21 % 
appearing in the urine and 54-80% appearing in the faeces. 
In a study by Costlow and Manson in 1983 [125] a single oral dose of 120 mg/kg 
[14C]nitrofen was given to pregnant rats on day 11 of gestation. Maternal blood [14C]-
concentration peaked 7-9 h after dosing at approximately IOl'g/ml 14C (calculated as 
nitrofen). The half-life in the maternal blood was 8 days. In the embryonic compartment, 
14C was first detected 2-3 h after dosing, peaked at 4-6 h after dosing at 50 ppm and 
declined to half of that initially seen by 24 h (the maximal studied period for the 
embryo). 
A follow-up study by Brown and Manson [127] on day 10 of pregnancy showed 
accumulation in maternal fat for over 72 h. Peak levels were reached in other maternal 
organs after 3-12 h; the plasma half-life was estimated to be 42 h. Radioactivity was first 
detected in the embryonic compartment at 3 h and continued to increase through the 72 
h time point. Despite this accumulation of activity in the embryo over tirue, the actual 
levels found in the embryonic compartment were low (about 1%). After 48 h there was 
redistribution of the parent compound from the maternal fat to other maternal organs 
and the embryo. 
2.14 Possible mechanisms in nitrofen teratogenicity 
It is suggested [128] that nitrofen exerts its teratogenic effect through specific 
mechanism(s) of action; the pattern of visceral malformations that occur in the absence 
of overt maternal toxicity or embryolethality/cytotoxicity suggest that the compound 
perturbs processes unique or highly selective for embryonic differentiation. 
Approximately 20 different metabolic products, including intermediates and conjugates, 
have been identified in adult rats after nitrofen exposure; only the parent compound (2,4-
dichloro-4'-nitrodiphenyl ether) could be detected in the embryo. 
Experiments [128] implied that it is the number and position of chlorine groups on the 
nitrofen molecule and not the nitro group that determines the teratogenic activity. The 
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absence of the stable endpoint of the nitroreduction pathway, the 4' -amino metabolite, 
in embryonic tissue suggests that this pathway may not be relevant for its teratogenic 
effect. 
Nitrofen, as a diphenyl ether compound, has a stereochemical configuration similar to 
thyroid hormone. 
Figure 3. The postlllated scheme of lIitroJell metabolism ill the rat [pennissioll of 125}. 
Both possess diphenyl ether ring structures in which aromatic rings are inclined at an 
angle of 120· and the planes of the aromatic rings are perpendicular to each other. , 
Manson et aL [128,129] examined the influence of nitrofen exposure on the 
hypothalamic-pituitary-thyroid function in nonpregnant, pregnant and fetal rats and 
attempted to relate alterations in thyroid hormone status to teratogenicity. 'TIley showed 
that co-administration of T4 with nitrofen to thyroidectomized pregnant rats during days 
6 - 15 of gestation, resulted in a 70% reduction of the frequency of malformed fetuses 
compared with nitrofen exposure alone [128]. 
The interpretation of this research is that nitrofen exposure results in a thyreomimetic 
challenge to the conceptus, In the case of the fetal lung, this was manifested as a 
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transient stimulation of lung differentiation at the expense of lung growth. This concept 
was already described in 1968 by Hamburgh for nervous tissue [130J; thyroid hormone 
alters the course of development in neural tissues by inhibiting proliferation and 
stimulating differentiation. 
The real mechanism of nitrofen teratogenesis remains unclear. The proximate teratogen 
could be the parent compound itself which directly binds to the embryonic nuclear 
receptors for TI, leading to altered differentiation of target organs. Alternatively, 
increased availability and placental transport of maternal thyroid hormones could be the 
proximate source of the thyreomimetic challenge to the embryo. 
Zeman et al. [131 J described reductions in DNA, RNA and protein contents in the lungs 
and also other organs except the brain; suggesting that the encountered organ weight 
deficits are the result of a reduced cell population. 
Lau et al. [132J gave nitrofen (20 or 40 mg/kg/day) to pregnant rats during days 10-13 
of gestation and investigated the effects on cardiac structure and function in newborns. 
They found marked depression of heart rate and abnormal electrocardiographicy (ECG) 
profiles, together with respiratory distress. The postnatal mortality was significant higher 
than controls. The percentage CDH was 14% and 50% in the mentioned dosage groups; 
there were no survivors after 24 h in the CDH groups. They observed an overall (CDH 
and non-CDH) improvement in heart rate after extra oxygen supply; they concluded that 
other more subtle morphological and physiological factors which contribute to improper 
systemic delivery and cellular utilization of oxygen may be involved. The high mortality 
can not be accounted for by the anatomical changes to the rat heart and diaphragm. 
In 1988 Lau et al. [133J continued research in this experimental setting and described 
that the lungs in the nitrofen animals were smaller, did not exhibit any specific pathologic 
lesions, but bad a simplified and immature appearance. The static compliance of the 
total system, derived from pressure/volume curves of the hysteresis loops was also 
significantly reduced. They found a CDH percentage of 50% in Sprague-Dawley rats and 
concluded diaphragmatic hernia does not seem to account for all the deficient lung 
compliance. 
In all these studies there was no intention to use nitrofen as a specific inductor of CDH. 
It was given to pregnant animals for a prolonged period and never as a pulse dosage at 
a critical phase in lung development. The prolonged gavage allowed the induction of 
mUltiple malformations, greatly influencing the final conclusions. 
2.15 Specific aims 
The specific aims of this thesis are: 
1. To establish a reliable and reproducible animal model of CDH using the herbicide 
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nitrofen in pregnant rats, and to compare this model to the human situation. 
2. To evaluate differences in the embryological/fetal development of the lung in CDH 
rats. 
3. To evaluate biochemical, histological and functional differences following artificial 
ventilation of healthy and CDH newborns. 
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Abstract 
EXPERIMENTALLY INDUCED 
CONGENITAL DIAPHRAGMATIC HERNIA 
IN RATS 
(J Pediatr Surg 1990;25:426-9) 
We report our experiments to induce congenital diaphragmatic hemia (CDH) in rats by 
means of administering a single dose of 2,4-dichlorophenYI-p-nitrophenyl (Nitrofen) on the 
tel/th day of gestation. The rat mode!, includil/g a control group, was used to evaluate lung 
development al/d the presence of lung hypoplasia by morphometrical analysis. We found that 
the single dose of Nitrofen given five days before the nonnal closure of the diaphragm in the 
rat leads to a high incidence of diaphragmatic hemia -mainly on th right side- and highly 
abnonnallung development (hypoplasia) comparable with the human sitl/ation.Eoth lung 
weight/bodyweight index as well as radial alveolar COUI/ts were significantly lower in animals 
with CDH (p < 0.05). This animal model offers a good opportunity to study abnonnallung 
development in relation to ventilatory capacity and pulmonary vascular reactivity. 
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INTRODUCTION 
The high mortality rate due to congenital diaphragmatic hernia (CDH) remains a major 
challenge for pediatric surgeons and neonatologists. Many questions concerning 
pulmonary vascular abnormalities, the extent of lung hypoplasia and its reaction pattern 
on artificial ventilation remain (1,2,3). These factors are hard to evaluate in the clinical 
situation. For this reason several workers (4·9) have used sheep for experimental studies. 
In a relatively late stage of fetal development diaphragmatic hernia was induced. Only 
Adzick (10) interfered with pulmonary development early in gestation. All these 
experimental series suffer from relatively small numbers, high costs and the need for 
surgical intervention to obtain a CDH model. 
In 1984 Iritani (11) published successful procurement of neonatal CDH after oral 
administration of 2,4-dichlorophenyl-P-nitrophenyl (Nitrofen) for prolonged periods 
during gestation in mice. However, no details about pulmonary development or 
morphometrical analysis of the lungs were presented. Nitrofen has been reported earlier 
as a teratogen (12) leading to a high incidence of CDH in certain rat strains, especially 
Sprague-Dawley. In our experiments to induce CDH, Nitrofen was used to study lung 
development and to evaluate the presence of lung hypoplasia by morphometrical analysis. 
MATERIAL AND METHODS 
Female Sprague-Dawley rats, weighing between 200-269 g bodyweight (Centraal 
Proefdierenbedrijf Harlan, Zeist, The Netherlands) were mated overnight (during 12 
hours) with proven Sprague-Dawley males. The day of mating was considered as day 0 
of pregnancy.The animals were housed separately in an airconditioned room; water and 
food (Rat Diet, Hope Farms, Woerden, The Netherlands) were supplied ad libitum. 
Mter mating, females were divided into two group: Control and Nitrofen. At day 10 of 
pregnancy 115 mg/kg bodyweight of 2,4-dichlorophenyl-P-nitrophenyl (Nitrofen) 
dissolved in olive oil was given as a single dose through a gastric tube.The control group 
were given the same volume of olive oil without Nitrofen. Pregnancy was continued 
without specific measurements. 
Tabla 1. Congenital Diaphragmatic Hernia in Rats 
BodyWeight 19I luog Right (mg) luog lelt (mgl L ..... gTotal{mgl LiS Rat;.:. Imglg) RiL Rat;':' (mg/mgl 
N,. Ise) !"I !"I !"I ISEj (SEj 
Before Birth 
Control 24 5.7 [0.3) 99.7 [10.0] 62[8.7) 161.7[17.3] 26.76 [S.30J 1.91[0.03) 
Nitrofen 23 5.0 [0.3'0 S6.0 (8.0]' 46.6[4.3)' 132.6 (11.2)' 26.34 (2.84,· 1.86 (0.12) 
CDK 11 4.8[9.3]0' 6S.6 (16.31" 33.6 (9.3)0' 91.9 [24. W' 19.29 [4.36,', 1.78 {0.221 
Aftar Binh 
Control 32 6.9 (0.31 73.4 (14.3) 3S.1 (S.5) 111.6 (22.5J 18.9 (4.0J 1.94 [0.12J 
Nitrofen 34 6.7 (0.4,· 67.9 (8.0)' 31.6(4.0" 89.4(11.7,· 16.8(1.70,· 1.84 [0.14J 
CDK 33 5.51 [O.4J· 48.2 (7.6Jo l 28.6 (4.6Jol 74.S (11.0)" 13.6 (1.60)" 1.83(0.26) 
Abbreviations! Sf. standard afrai; L/8, lung weighl/body weIght; R/L, right fung/left lung. 
OSignifiC<'lnt from control, P < .06. 
'Significant from Nitrofen, P < .05. 
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In both groups a part of the mothers were allowed to deliver spontaneously on day 22.5 
while on the remaining part a ceasarean section was performed on day 21 of gestation. 
The number of live births and the number of living newborns with respiratory 
insufficiency was evaluated. Following determination of bodyweight all animals were 
killed by intraperitoneal injection of an overdose of pentobarbital (Nembutal, Sanofi, 
The Netherlands) followed by autopsy (Stuckhardt 1984). 
The number of animals with a diaphragmatic defect, the position (right or left sided) and 
the size of the defect as well as the nature of the intrathoracic contents (liver, bowel, 
pancreas, stomach) were evaluated. The lungs were dissected and left and right wet lung 
weights were determined using a balance (Mettler, Haariem, The Netherlands) enabling 
calculation of lung weight/bodyweight ratio. 
In 26 newborns with CDH, left and right lung weight were measured and related to the 
size of the diaphragmatic defect and the intrathoracic contents. 
For our microscopic studies the pulmouary arterial trunk was cannulated and perfusion 
was performed ,vith Davidson solution (40 vol% ethanol 100%; 5 vol% acetic acid 96%; 
10 vol% formaldehyde 37%; 45 vol% saline, pH 7.3) under standard conditions until the 
pulmonary veins no longer contained blood.To prevent lung collapse after tracheal 
cannulation, the lungs were inflated with room air under a constant pressure of 20 em 
H20 while arterial perfusion with Davidson solution was performed. Following 
perfusion the trachea was ligated and the whole animal was placed in fixative for at least 
24 hours (13). After fixation the lungs were dissected out of the thoracic cavity and 
processed for routine histology after embedding in paraffin. Six micron slides were made 
and stained with haematoxylin eosin (HE), Elastica Van Giesson (EVG), Alcian Blue 
or Azan. 
Morphometric analysis to determine radial alveolar count (RAe) (14,15) was performed 
from at least 3 different slides using magnification 25Ox. At least 10 RAC's per slide were 
evaluated. 
In the group of newborn animals with CDH radial alveolar counts were plotted versus 
lung weight/bodyweight index according to Askenazi (16). The same procedure was 
performed in a number of animals (N = 10 for each group) irrespective of the presence 
of a CDH in the Nitrofen group as well as in the untreated controls. 
Statistical Analysis 
All data are reported as mean ±. Standard Deviation, unless otherwise stated.Differences 
between the means were tested by the Mann-Whitney-Wilcoxon test for unpaired 
samples. Where it was allowed the Student T-test was also used. P values less than 0.05 
were considered to be statistically significant. 
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Figure 1. fA] Typical example of congenital diaphragmatic hemia illnewbom rat. LII IUllg; 
Liv liver; Es esophagus; D remaining part of the diaphragm fBJ Posterior sectioll observed 
through the upper half of the thorax. Henda is located 011 the left side. (H&E, 6/1111 slide 
original magnificatioll x60) 
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RESULTS 
Only in the newborn group with CDH was severe respiratory insufficiency observed 
leading to death in more than 80% of the animals within two hours postpartum. High 
ventilatory rate, persistent cyanosis with the inability to suck spontaneously were 
observed. The total percentage of CDH in the treated group ranged between 30-80% 
with a mean value of 40 %. In animals who did not acquire CDH no obvious respiratory 
difficulties were notified, like in the control group. Mean body weights; lung weights, 
lung/body weight ratio (L/B) and right/left lung weight (R/L) index including standard 
deviations are shown in Table I. The mean bodyweight differed significantly in the 
Nitrofen treated group compared with controls. The same was observed for total lung 
weight both at day 21 as well as post partum. 
Right sided CDH occurred eight times more than left sided CDH. In most animals the 
defect was observed in the posterior region of the right diaphragm, while in the rninority 
of cases an almost total absence of the right herni-diaphragm was observed. A part of the 
whole right liver lobe extended in the right herni-diaphragm directly adjacent to the right 
lung (see figure 1). In a number of cases bowel loops and pancreas were positioned in 
the right hemi-thorax. Eventration and laxation of the diaphragm was never 
observed.Figure 2 shows contra- and ipsilateral lung weight in CDH are shown in 
relation to the size of the diaphragmatic defect. No significant correlation was found. 
between the size of the defect and the ipsilateral lung weight. In all cases a significant 
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decrease in lung weight was also observed on the contralateral side. This is also 
illustrated by the values of the R/L index : throughout the six groups there is no 
significant difference (table I). In all cases of right sided diaphragmatic hernia the right 
and left lung weight was significantly lower than in control animals. No correlation was 
found between the presence of liver and/or bowel loops, the extent of the diaphragmatic 
defect and the corresponding lung weight. 
Microscopic evaluation in case of diaphragmatic hernia revealed thick intra-alveolar 
septa, retarded development in comparison with controls resembling the canalicular stage 
of development. Only a few number of sacculi which are normally present at birth were 
notified. Radial alveolar count was significantly lower in CDH and Nitrofen treated 
animals than in controls (Figure 3). Animals treated with Nitrofen without CDH, 
however, showed high radial alveolar counts than animals with diaphragmatic defect. The 
radial alveolar counts plotted against lung-bodyweight index indicate severe hypoplasia 
of the lung in case of diaphragmatic hernia. 
DISCUSSION 
CDH has be~n induced in sheep to mimic the diminished lung growth and the effect of 
antenatal repair on the developing lung (4-9). Besides the technical problems related to 
the manipulation of these animals, interference with pulmonary development in these 
animals has heen rather late (second trimester) or resulted in high mortality following 
early intervention (10). 
It is generally accepted that a diaphragmatic hernia in human is the result of defective 
development of the diaphragm during the first trimester of gestation, leading to 
abnormal lung development far before the critical period (17) in lung development 
(between 20th and 24th week of gestation). Although Iritani (11) reported the incidence 
of CDH in a strain of mice after prolonged exposure to Nitrofen and a high rate of 
mortality, his study focused mainly on the abnormal development of the diaphragm itself 
in relation to the phrenic nerve. Detailed information about the morphological 
development of the lung and consequently of the significance of this animal model for 
understanding the etiology and pathogenesis of the human situation remains unclear 
from his report. 
Our results show that a single dose of a herbicide given five days before normal closure 
of the diaphragm in the rat (18) leads to high incidence of diaphragmatic hernia (mainly 
on the right side) and severely abnormal lung development (hypoplasia) comparable with 
the human situation. We cannot explain why the diaphragmatic defect occurs in a high 
incidence on the right side. Data from relevant literature show that tilning of the 
administration of the herbicide is essential to induce a high incidence of CDH suggesting 
a critical period of development to interfere with normal diaphragmatic development 
(12,19).It is speculated that a different time of Nitrofen administration could lead to a 
different ratio of right and left sided CDH. The abnormal lungs in the Nitrofen exposed 
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rats without CDR suggest that the lungs are the primary target organ for Nitrofen (19). 
The significance of this observation and the fact that no clear connection was found 
between the size and place of the the missing part in the diaphragm and the ipsilateral 
lungweight may lead to new thoughts about the primary problem in CDR. 
The idea that pUlmonary hypoplasia and diaphragmatic hernia is dependent only on the 
compression of the early developing lung as well as the position of the bowel loops in 
relation to the diaphragmatic defect during early stages of development needs re-
evaluation. 
It is concluded that CDR can be successfully induced in rats at an early stage of 
development before the normal time of closure of the diaphragm. This animal model 
offers a new opportunity to study abnormal lung development related to both the 
ventilatory capacity as well as to pulmonary vascular reactivity. 
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Abstract 
Nitrofen-Induced Diaphragmatic Hernias 
in Rats: An Animal Model 
(J Pediatr Surg 1990; 25:850-854) 
In embryological temls, pathogenesis of congenital diaphragmatic hemia (ICDH) associated 
with pulmonary hypoplasia is still unclear. However, it is known since 1971 that Nitrofen (2,4 
dichloro-phenyl-p-nitrophenyl ether) can induce anatomical maifonnations in rats including 
diaphragmatic hemias. On order to establish an animal model of the embryogenesis of CDH, 
the effect of Nitrofell all the developing diaphragm was studied. Thirty-three pregnant female 
rats were exposed to Nitrofen. Five unexposed pregnant rats served as controls. III the first 
set of experiments, single doses of Nitrofen were given between the 9th and 13th day of 
pregnancy. In the second set of experiments, dosages of 50, 100, and 150 mgper animal were 
given on day 11 of pregnancy only. Postnatally the litlers (469 newbom rats) were dissected 
to record the incidence of diaphragmatic maifonnations. The results were: (1) most hemias 
occurred after administration of 100 mg Nitrofen on day 9 (42%) and 11 (59%); (2) 
left-sided hemias were observed only after exposure to Nitrofell all day 9; (3) after exposure 
on day 10 or later all hemias were on the right side; and (4) Fifty-nine percent of the 
newbom rats exposed on day 11 had CDH. These resnlts show that this model is suitable for 
further embryological investigations all the development of CDH. 
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The pathogenesis of congenital diaphragmatic hernia (CDH) associated with pulmonary 
hypoplasia is poorly understood[l]. Most authors speculate that the intestine enters the 
thoracic cavity through a dorsolateral diaphragmatic defect with subsequent secondary 
hypoplasia of the lungs. However, this sequence of embryological events has not been 
studied previously. Progress has been hampered by lack of an appropriate animal model 
allowing definition of morphological changes during embryogenesis specific for this 
malformation. 
Since 1971, the embryotoxicity of the herbicide Nitrofen (2,4.dichloro·phe· 
nyl·p·nitrophenyl ether) has been well known[2]. After exposure to Nitrofen several 
malformations were observed in rats, including diaphragmatic hernias[3·6]. 
In order to use this substance for the establishment of an animal model for 
diaphragmatic hernias, the following questions need to be answered: (1) what percentage 
of newborn rats will present with diaphragmatic hernias after exposure to Nitrofen during 
embryogenesis? (2) what dosages of Nitrofen are necessary to induce these 
malformations? and (3) in what gestational age is the embryo most sensitive to Nitrofen? 
MATERIALS AND METHODS 
Adult female Sprague· Dawley rats weighing between 210 and 315 g (mean, 271 g), were 
bred under standard laboratory conditions. After controlled overnight mating, pregnancy 
was verified by means of the vaginal smear method. The day of positive smear was rated 
as day zero of pregnancy. 
The pregnant rats were exposed to orally administered Nitrofen (Wako Chemicals, 
Neuss, West Germany). The substance was mixed with 20 g of moistened commercial rat 
chow (Altromin, Lage, West Germany) and offered to the rats after a 24·hour period of 
fasting. Rats not consuming this mixture within 12 hours were excluded. Using this 
method, 33 pregnant rats were successfully exposed to Nitrofen. Thereafter the rats were 
again supplied with food and water ad libitum and spontaneous delivery was allowed. 
Five animals, after undergoing a 24·hour fast, served as controls. Two experimental 
designs were used. In a first set of experiments, a single dose of 100 mg Nitrofen was 
given to rats on day 9, 10, 11, 12, or 13 of pregnancy. There were five rats in each group. 
In a second set of experiments, dosages of 50, 100, or 150 mg of Nitrofen were given to 
rats on day 11 of pregnancy ordy. There were four rats in each groups receiving 50 or 150 
mg Nitrofen. The animals comprising the lOG·mg group were taken from the first 
experimental set (five animals). 
After spontaneous delivery all newborn rats were killed, promptly dissected 
microscopically, and than fixed in Bouin's solution. The number of CDHs per litter, the 
size, and the location were recorded. Statistical analysis was performed using 
Kruskal·Wallis one·way analysis of variance test in experiment 1 and regression analysis 
(linear model) in experiment 2. 
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RESULTS 
A total of 469 newborn rats were dissected microscopically (Table 1). Among 388 rats 
born to mothers exposed to Nitrofen during pregnancy, 94 had diaphragmatic hernias 
(24%). In aU cases of CDH the liver was in the thoracic cavity. Additionally, in 15 of 94 
newborns with CDH (16%) the stomach or the intestine was also present in the thoracic 
cavity. 
Table 1. Overall Results 
Nitrofen 
Control 
Total 
Group 
Observed hernias (total) 
No. of Female Rats 
33 
6 
38 
No. of Newboms 
388 
81 
469 
94(24%) 
NOTE. Hernias were observed In the Nitrofen group only. 
Malformations of other organ systems were not observed on routine disse~tions in this 
sample. Eighty-one newborns (control group) were not exposed to Nitrote~ in utero. 
None of these newborns had CDH. 
The results of the first set of experiments are shown in Tables 2, 3, and 4. In Table 2, 
the relative frequency of diaphragmatic hernias, the maternal body weight, and the 
number of siblings per litter are recorded. The relative frequency of diaphragmatic 
hernias was 42% for the day 9 group and 59% for the day 11 group. This was statistically 
significant compared with the data from groups 10, 12, and 13 (P < .002). Maternal body 
weight and number of siblings were equally distributed. Statistical analysis failed to 
detect any impact of maternal body weight or number of siblings on the relative 
frequency of diaphragmatic hernias. 
Table 2. Results of the First Set of Experiments 
Day of ExposlJ(e Sibs/litter (avg) Weight (mal) In 9 (avg) Hernias I%J (avg) 
9 11.4 260.8 41.7" 
10 10.8 290.4 18.8 
11 10.4 276.0 69.0· 
12 11.2 284.6 7.2 
13 14.0 270.0 6.0 
NOTE. Neither tho number of siblings per litter nO( maternal weight 
influenced the relative number of observed congenital diaphragmatic 
hernias. The day of exposure was the only variable that significantly (.) 
influenced the number of hernias. 
Abbreviations: sibs, siblings; mat, maternal. 
"p < .001. 
Table 3. Size of Observed Hernias (First Experiment) 
Size 
Small 
Medium 
large 
No. 
21 
16 
36 
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In Table 3 the size of CDH is recorded. The size of the hernia was considered as small 
when it was totally covered by the lung, and as medium when liver and bowel loops 
represented less than 50% of the thoracic contents. The size of the hernia was 
considered large when over 50% of the thoracic contents were liver and/or bowel loops. 
According to this score, 21 small hernias (Fig 1), 16 medium-size hernias (Fig 2), and 36 
large hernias (Fig 3) were observed. Table 4 shows the location of the observed hernias 
Day of Exposure 
9 
10 
11 
12 
13 
Tabla 4. location of Hernias 
l,. Right 
14 
B 
31 
4 
4 
Bilateral 
3 
on the right or left side depending on the day of Nitrofen exposure. The vast majority 
were seen on the right side. The left side was involved only in animals exposed on day 
9. These rats also showed bilateral hernias. 
The results of the second set of experiments are shown in Table 5. The highest number 
of diaphragmatic hernias was observed in the group receiving 100 mg of Nitrofen per 
animal. Using regression analysis, there was no linear correlation between the number 
of hernias observed and the dosage of Nitrofen exposure in the range between 172 and 
641 mg/kg body weight (correlation coefficient .4447, r' = 19.8%). . 
No left-sided hernias were observed in this experiment. The size of the hernias was 
always small in the 50-mg group, although in the 100- and 1 50-mg groups medium and 
large hernias were regularly observed. 
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Fig 1. Typical view of a small right-sided CDH in a lIewbom rat after Nitrofell sxposllre. 11le small kllob-like 
sin/chlre is liver (Ii) alld represents the dorsally located CDR: Ill, IlIlIg (lifted with forceps); di. diaphragm. 
Fig 2. Typical view of a medium-sized right-sided CDH III a IJewbom ral after Nitrofell exposure. LUllg is 
dissected out. 11le liver (Ii) hemiates ililo the thoracic cavity (hrough a dorsal diaphragmatic defect (black 
a"ows). di, Velltral diaphragm,' he, heart,. es, esophagus,' pit, phrenic lIerve with vein cava illferior. 
Fig 3. Large rigllt-sided CDH ill a lIewbom rat after Nltrofen expOSllre. TIvo lobes of liver (Ii) alld Ilites/blOl 
loops hemiale througll 8 dorsal diaphragmatic defeci. 11le IImg (III) Is smaJt.· vd, velltral part of diaphragm. 
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DISCUSSION 
Although surgical treatment of CDH is simple, the mortality associated with this 
malformation is still high. This is due to the fact that in many of these children the lungs 
are too hypoplastic to allow normal extrauterine life even in full-term babies [7,8]. Many 
investigators state that lung hypoplasia results from intrathoracally displaced viscera 
preventing normal development of the lungs[9-13]. This view has been supported by data 
of DeLorimier et al[14], and Harrison et al[15], obtained in a sheep model of CDH. As 
a consequence, fetal surgery has been advocated, including in utero correction of CDH, 
aimed at preventing severe intrauterine lung damage[16]. However, the beneficial effects 
of intrauterine intervention, effective in the sheep model, proved of limited value in 
humans[17]. Pathogenesis of CDH and the associated hypoplasia of the lungs remained 
elusive. To gain precise informations about the natural history of CDH, its development 
must be studied in a suitable animal model using embryos in different stages. 
This model should meet the following criteria. The number of hernias per litter should 
be high. Phases of high and low sensitivity to the substance used to induce the 
malformation' should be clearly discernible. Using 100 mg Nitrofen on day 11 of 
pregnancy, diaphragmatic hernias could be observed in almost 60% of the newborns. 
Table 6. Results of Second Set of ExperIments 
TOlal Oo»g.a of Siblingi/UU&r Malernal Weighl Hernias Oosa\)<lmg S",,' l • ., 
Ni!loren Imgl (avgl Igllavgl I%llavg) Nittogen/kg I""gl Hernia 1%1 ilemia(%) 
0 16.2 284.6 0 0 0 0 
60 11.8 249.0 11.1 202.6 100 0 
100 10.4 276.0 69.0· 369.0 61.6 48.6 
160 11.3 260.6 21.8 602.0 67.1 42.9 
NOTE. The number of hernias depends on/yon the doSIIg<'! of Nitrofen. Apeak results after the 100 mg dosag<'!; a highM dosllg<'! does not result in more 
hernIas . 
• p < .002. 
This number is adequate for further embryological studies. These data are in accordance 
with the study of Iritani[6], who demonstrated CDH in up to 80% of newhorn mice 
exposed to Nitrofen continuously between day 5 and 15 of pregnancy. These data were 
also confirmed by a previous study from our laboratories[18]. Pulse·feeding of Nitrofen 
for a maximum period of 12 hours demonstrates the presence of two sensitivity peaks, 
one on day 9 and a second on day 11 of pregnancy. This is precisely the time when lung 
anlage and diaphragmatic primordium start to develop in rat embryos[19]. Moreover, in 
this period the early anlage of the lung and primordium of the diaphragm are in close 
spatial relationship[20]. After day 12, Nitrofen sensitivity sharply declines, confirming 
observations made earlier by Iritani[6]. This means that sensitivity to Nitrofen is minimal 
at the time when the pleuroperitoneal canals disappear. This has been shown to take 
place on day 17 of pregnancy in normal rat embryos[20]. Consequently, Nitrofen seems 
to interfere with the formation of the diaphragmatic anlage rather than with the closure 
of its so·called pleuroperitoneal canals. Interestingly, left-sided diaphragmatic hernias 
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were only observed after exposure to Nitrofen on day 9. If Nitrofen was given on day 10 
or later only rigbtsided hernias were observed. Thus, Nitrofen sensitivity peaks earlier 
on tbe left side tban on the right side. This means that in early embryological stages the 
left diaphragm anlage is more advanced in development than the right anlage, contrary 
to what had been assumed heretofore in human embryos[9-131. 
These results demonstrate that the described model is an valuable tool for further 
embryological investigations of CDH and the associated pulmonary hypoplasia. This 
model allows us to address the fOllowing questions: (1) which parts of the diaphragm are 
affected during early stages of the malformation? (2) at what time signs of pulmonary 
hypoplasia become visible? and (3) does pulmonary hypoplasia occur as a primary event 
or as a result of displaced, intrathoracic viscera? 
REFERENCES 
1. Kluth D, Petersen C, Zimmerman HJ: The developmental anatomy of congenital diaphragmatic 
hernia. Pediatr Surg Int 2:322-326, 1987 
2. Ambrose AM, Larson PS, Borcelleca JF, et al: Toxicological: ~studies on 
2,4-dicWorophenyl-p-nitrophenyl ether. Toxicol Appl PharmacoI19;263-275, 1971' 
3. Kimbrough RD, Gaines TB, Linder RE: 2,4-DicWorophenyl-pnitrophenyl ether (TOK), effects on 
the lung maturation of rat fetus. Arch Environ HeaJlh 28:316-320, 1974 
4. Nakao Y, Iritani 1, Kishimoto H: ExperimentaJ animal model of congenital diaphragmatic hernia 
induced chemically. Teratology 24:11A, 1981 (abstr) 
5. Costlow RD, Manson JM: The heart and diaphragm: Target organs in the neonatal death induced 
by nitrofen (2,4-dicWoro-phenylp-nitrophenyl ether). Toxicology 20:209-227, 1981 
6. lritani I: Experimental study on embryogenesis of congenitaJ diaphragmatic hernia. Anat Embryol 
169:133-139, 1984 
7. Harrison MR: Fetal diaphragmatic hernia, in Puri P (ed): Congenital Diaphragmatic Hernia: 
Modern Problems in Paediatrics, vol 24. Basel, Switzerland, Karger, 1989, pp 130- 142 
8. Bohn D, Tamura M, Perrin D, et al: Ventilatory predictors of pulmonary hypoplasia in congenital 
diaphragmatic hernia, confirmed by morphologic assessment. J Pediatr 111:423-431, 1987 
9. Broman I: Uber die Entwicklung des Zwcrchfells beim Menschen. Verh Anal Ges 16:9-17, 1902 
10. Bremer JL: The diaphragm and diaphragmatic hernia. Arch Pathol 36:539·549, 1943 
11. Wells U: Development of the human diaphragm and pleural sacs. Contr Embryol Carnegie Inst 
35:107-137, 1954 
12. Gray SW, Skandalakis JE: Embryology for Surgeons. Philadelphia, PAl Saunders, 1972, pp 359·385 
13. Starck D: Embryologie. New York, NY, Thieme, 1975, pp 488·500 
14. deLorimier AA, Tierney DF, Parker HR: Hypoplastic lungs in fetal lambs with surgically produced 
congenital diaphragmatic hernia. Surgery 62:12-17, 1976 
15. Harrison MR, Jester JA, Ross NA: Correction of congenital diaphragmatic hernia in utero. I. The 
model: Intrathoracic baJloon produces fatal pulmonary hypoplasia. Surgery 88: 174· 182, 1980 
16. Harrison MR, Bressack MA, Churg AM: Correction of congenital diaphragmatic hernia in utero. 
II. Simulated correction permits fetal lung growth with survival at birth. Surgery 88:260·268, 1980 
17. Harrison MR, Langer JC, Adzick NS, et aJ: Fetal diaphragmatic hernia: Prognostic factors and 
preliminary experience with repair before birth. Presented at the 20th Annual Meeting of the 
American Pediatric Surgical Association, Baltimore, MD, May 28·31, 1989 
18. TenbrinckR, Tibboel D, Gaillard JU, et al: Experimentally induced congenital diaphragmatic hernia 
nitrofcn induced CDH 54 
in rats. J Pediatr Swg 25:426·429, 1990 
19. Witschi E: Development of the rat, in Altman P, Dittmer DS (cds): Growth Including Reproduction 
and Morphological Development. Washington, DC, Fed Soc Experiment Bioi, 1%2, pp 304·414 
20. Kluth DJ Petersen C, Zimmermann HJ, ct at: The embryology of congenital diaphragmatic hernia, 
in Pori P (cd): Congenital Diaphragmatic Hernia: Modern Problems in Paediatrics, vol 24. Basel, 
Switzerland, Karger, 1989, pp 7·21 
ABSTRACT 
PULMONARY VASCULAR ABNORMALITIES 
IN EXPERIMENTALLY INDUCED 
CONGENITAL DIAPHRAGMATIC HERNIA IN RATS. 
(J Pediatr Surg 1992; 27:862.5) 
In infants with congenital diaphragmatic hemia (CDR), abnonnalities of (he pulmonary 
arteries are present cOllSisting of increased medial wall thickness and decreased extemal 
diameter. This fOnlls the morpholOgical substrate for persistent pulmonary hypertension, one 
of the leading causes of the high mortality in these patients. To elucidate the significance of 
these abnonnalities, experimental models are required that mimic as close as possible the 
human situation. 
In our rat model we are able to study the hypoplastic CDR lungs extensively. In this study 
we peifonned a histological evaluation of the pUlmonary arterial bed in the cOllfrol group 
and the nitrofen treated group in which the latter was subdivided in CDR and nonnal aspect 
diaphragm. We examined the newbom rats after peifusion of the pulmonary arteries with 
barium gelatine with subsequent fixation. 
At the level of the respiratory bronchioles significant differences in the vessels were found 
cOllSisting of decreased extemal diameter, increased wall thickness as percentage of the 
extemal thickness in CDR lungs compared to controls. Abnonnal muscularization of the 
peripheral branches of the CDR pulmonary arteries was also found. 
We concluded that the rat model strongly resembles the human situation conceming the 
arterial bed in the lungs. 
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INTRODUCTION 
Congenital diaphragmatic hernia (CDH) is a serious anomaly of the diaphragm and lungs 
in newborns; the mortality rate of approximately 30 to 60 percent has not changed 
significantly in the last 30 years [1]. The incidence of this disease is about 1:3000 
newborns. The high mortality and morbidity of patients with CDH is due to the presence 
of pulmonary hypoplasia, uni- or bilateral [2] in combination with microscopically well 
defined abnormalities of the pulmonary vessels [3-5]. 
The course of CDH is often unpredictable and progress in ways of treatment has been 
hampered by lack of an appropriate animal model to investigate the morphological, 
biochemical and physiological changes during embryogenesis and immediately after birth 
without the effects of intensive care treatment. Clinical research is based on comparison 
of different ventilation techniques [6] (e.g. conventional, high frequency oscillation) or 
alternative methods of treatment (e.g. extracorporeal membrane oxygenation) [7]. 
Besides puhnonary hypoplasia, persistent fetal circulation (PFC) determines the final 
outcome in CDH patients. A strong and often unpredictable vasoconstrictive response 
of a hypertrophied hypermuscularised pulmonary arterial bed leading to increased 
pulmonary 'vascular resistance appears to be one of the most important mechanisms 
leading to the often fatal hypoxemia in these newborns. A broad spectrum of vasoactive 
drugs [8] have been used in an attempt to treat pulmonary hypertension, however, 
without success in many patients. To date research in animals has been in sheep with 
induced CDH at different stages of puhnonary development [6,9-10]. Only Adzick 
interfered with pulmonary development early in gestation in sheep (60-63 days). 
However, detailed studies on the presence of puhnonary vascular abnormalities are 
scarcely available in these animal studies[lO]. 
Since 1971 the embryo toxicity of the herbicide nitrofen (2,4-dichlorophenyl-p-nitrophenyl 
ether) has been known in rats [11] and mice [12]. The heart and lungs are suggested as 
primary target organs [13]. 
In former sjudies on induction of CDH in rats we reported differences in lung weight 
and mc;>rphological changes that established pulmonary hypoplasia [14].The dose and time 
related' effects of nitrofen application in relation to the incidence and side of 
diaphragmatic' defect were also described [15]. This study aims to investigate the 
presence of pulmonary arterial abnormalities in a CDH model. Data are compared to 
those of a control group of newborn rats (tess than 4 hours after birth) and to data in 
humans with CDH as described in the literature [3-5,16]. 
MATERIAL AND METHODS 
Three groups of animals were used: 1: Control (C) receiving only olive oil, 2: nitrofen 
(N) despite of receiving nitrofen, they developed an intact diaphragm and 3: CDH group 
(H) animals receiving nitrofen and developing a one-sided diaphragmatic hernia. Each 
group consisted of 6 animals; the group H comprised of 4 left-sided and 2 right-sided 
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hernias. 
Animals were obtained as described earlier [14J, for this study only spontaneously 
delivered animals were used. These newborns were killed by an intraperitoneal injection 
of sodium pentothal (200 mg/kg of body weight).The chest wall was removed and the 
pulmonary arterial bed was injected and perfused through a cannula into the right 
ventricle with barium-gelatin mixture at 60 0 C and constant pressure [17J.The perfusion 
was stopped when this white solution reached the visceral pleura in all segments leading 
to so-called 'snow flocks'. Subsequently tracheal cannulation and lung fixation with 
Davidson solution (40 vol % ethanol 100%; 5 vol % acetic acid 96%;·10 vol % formal-
dehyde 37%; 45 vol % saline; pH 7.3) was performed; fixation was maintained under 
constant pressure of 20 em water[17J. After fixation (for 2 days), the lungs were dissected 
out of the thoracic cavity. The number of animals with a diaphragmatic defect, the 
position (right or left sided) and the size of the defect as well as the contents of the 
thorax (liver, bowel, stomach) were observed. An arteriogram was taken of eaep pair of 
lungs. 
Fig 1. Arteriogram showing a confrollullg (a) alld a right-sided congenital diaphragmatic hen/;a lfmg(b). 17,ere 
is no apparent reduction ill tire /lumber of arteries after injecting Ihe pulmonary Inmk with barium-gela/ill 
mixture. 
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Histologic preparation and light microscopic techniques. 
The dissected lungs were processed for routine histology resulting in paraffin embedding 
of total lungs. Six I'm frontal sections sbowing both lungs were made and stained with 
haematoxylin-eosin and Lawson combined with elastica van Gieson staining. Two 
different sections per pair of lungs were observed (12 sections per group). Analysis of 
each section was carried out in a blind fashion by means of an ocular micrometer (1 unit 
is 1.48 I'm, Zeiss Optical Industry, Germany) and standard magnification (10 x 63) A 
total of at least 35 arteries of each animal (15 from each section) were examined. For 
each artery external diameter, wall thickness, wall structure (muscular, partially muscular, 
or nonmuscular) was noted [5,18]. Also the airway that they accompanied was noted 
(conducting airway, (CA), or respiratory bronchiole, (RB». Wall thickness was defined 
as the distance between the luminal surface and the adventitia. External diameter was 
defined as the distance between the outer edges of the adventitia. The percentage wall 
thickness (2x wall thickness/external diameter) x 100% was calculated [17]. The mean 
value for each group was calculated with respect to the accompanying structure. No 
correction wa~ made for processing and shrinkage factors [5]. A frequency tabulation of 
the artery structure was made depending on the accompanying airway structure [19]. 
Statistics 
All data are reported as mean ±. standard deviation. Differences between the means 
were tested by analysis of variance. Further tests used were the Student T-test and the 
Mann-Whitney-Wilcoxon test. P-values less than 0.05 were considered to be statistically 
significant; a specification of the p-values is not indicated. 
Table 1. Number. SI~e. and Stru(:ture 01 Arteries In Three Groups of NewboTll Rats 
Ac(:ompanying Airway N().ofAfte"es f.tematOiamete, Wait Tt,ic\.ness 
landm~,k hamined pe' Anim~1 !,.m) !% e.1 d;~mete'l 
Conducting airways 
Control '0 115 (59) 8.1 (2.1) 
Nitrolell 
" 
98 (45)' 9.4 (3.61 
COH 19 65 (29)'t 18.9 (7.3)·t 
Respiratory,bronch ioli 
ContlOl 
" 
46 (14) 11.7 (6.41 
Niuofen' 
" 
46(19) 11.1 (3.71 
COH '0 39(14)'t 183 (7.6't 
NOTE. AU values are mean (SO). Wan structure is e~pre$sed in relative frequency. 
'p < .05 v control. 
tP < .OS v nitlOlen. 
RESULTS 
1'1311 Stru(!u,e 
Muscul" (~.l P~«i.tMuicula'!··,1 
76 
" 75 16 
90 6 
13 
" 
'0 47 
45 
" 
tlonmUicul" ('!.l 
10 
4 
64 
33 
31 
The body weights of the animals were similar to our former study [14] C: 6.0 ±. O.3g: N: 
5.9 ±. 0.3g; H: 5.6 ±. O.4g. Lung weights were not determined in this study because of the 
use of barium gelatin instillation. 
The arteriograms showed remarkable structural conformity of the arterial tree in the 
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three groups with respect to the branching pattern and number of arteries. The dense 
background haze, produced by vessels too small to show up as individual lines was 
difficult to assess in these small lungs (Fig 1). 
The external diameter was reduced in the CDH group (Table 1). The wall thickness 
expressed as percentage of the external diameter was increased in the CDH group at 
both levels. This is due to decreased external diameter and to an increased wall thickness 
as well. 
A frequency distribution of the muscular, partial muscular, and nonmuscular arteries in 
the C, N, CDH groups, which is plotted against the external diameter (as described by 
Kitagawa [5]), revealed that in the CDH group each structural type is found in smaller 
arteries than in the C and N groups. Our distribution data are similar to those found by 
Kitagawa. 
Also the frequency distribution of the wall structure (M: P: N), independent of external 
diameter, but plotted against the accompanying airway landmark (Table 1.), shpws that 
the percentage of muscular arteries in CDH lungs differs from that of the control and 
nitrofen group at both surveyed levels; it shows a more peripheral extension of arterial 
muscularization in the CDH-Iungs. Fig 2 shows the difference at the alveolar level 
between the C and H group arteries. 
Fig 2. The difference betweetl cOlltrollung (a) alld left sided cOllgellital diaphragma,;c hemla IIl11g (b) at the 
same magnificatioJls (origillaI400xJ' Lawson/elastica vall Glesson staining). V,e differellce ill slntclure betweelJ 
COli trois and CDH ;s evidelJi/ the lalter showilJg thick walled sacculi alld a dellser slntchlre despite tlte same 
pressure at {lXa/ioll. 77le differellce ill artery sintchlfe all the alveolar level is evidellf. 17llck mllsclliarized walls 
III the CDH versus thillller walls ill cOllfrols/ also the extemal diameter of the cOllfrollarger. 17lis leads to tlte 
illcreased wall thickness as percentage from extemal diameter. 
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DISCUSSION. 
Lung hypoplasia in human newborns with congenital diaphragmatic hernia has been 
described by several authors [2-6]. 
Kitagawa [5] described the pulmonary vascular bed in a CDH patient; he reported the 
distribution of the muscular, partial muscular and nonmuscular arteries showing a shift 
to the left, indicating an extension of muscle into smaller vessels as far as preacinar 
arteries than is normal. Analysis of the wall structure revealed hyperplasia of the 
muscular coating. Little difference between left and right lung was found. Levin [4], Bohn 
[6] have analyzed the pulmonary arterial bed in the lung of infants who died of CDH; 
they found an increase in the muscle mass (medial width/external diameter ratio) and 
a reduction in the total number of vessels. Geggel [3] revealed structural differences in 
the lungs between infants with CDH who enter a honeymoon period after surgical 
correction and those who do not. In all the infants the cross-sectional area of the 
pulmonary arterial bed is decreased, but this is more severe in the no-honeymoon group. 
In the latter the arteries are smaller and their media thicker causing a greater reduction 
in luminal diameter. 
Adzick [10j' c~eated a diaphragmatic defect during the pseudoglandular phase of lung 
development in sheep; this resulted in gross lung hypoplasia, a marked decrease in the 
size of the pulmonary vascular bed, and abnormal extension of muscle in the intra-acinar 
vessels. Wallen [20] found that ligation of the left pulmonary artery in 105 day sheep 
caused significant decreases in left lung weight, volume displacement, future airspace, 
parenchyma tissue and capillary contents. Pulmonary arterial flow must be considered 
in evaluation of factors associated with pulmonary hypoplasia. 
In our model of experimental induced CDH, we found an increased wall thickness 
expressed as the percentage of external diameter both on the level of the conducting 
airways and respiratory bronchiole. The muscularization of the pulmonary arteries starts 
at arteries With a smaller external diameter, suggesting a further peripheral extension of 
the musc~la:r arteries in CDH lungs. The arteriograms showed no large differences 
betwee)l the three groups in branching pattern and number of arteries. 
There .are few data in the literature with which to compare our control group; the only 
one found was a study from Geggel [19]. Our data of the control group correspond well 
to that of Geggel. This author found a lower value for the wall thickness as percentage 
of the external diameter, this could be due to a slightly different way of measuring the 
wall thickness. He also found a slightly lower value for the external diameter in the 
respiratory bronchiole area with almost the same subdivision in wall structure. Lau [13] 
studied the lungs in nitrofen fed rats but he did not make a difference between the N 
and H groups. Also the pulmonary vessels structure was not considered in his study. Care 
has to be taken in comparing the models since we know that the time of administering 
nitrofen is important [15]. 
Comparing our model to the human situation we found a similar survival pattern as 
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described by many authors [3,4,6). We were unable to differentiate between the ipsi and 
contralateral lungs in the group H; because of the very derue structure on the herniated 
side we could not distinguish the accompanying airway landmarks very well in all the 
CDH lungs. 
CONCLUSION. 
Congenital diaphragmatic hernia can be induced in rats successfully in an early stage of 
fetal development. According to our study we can conclude that the pulmonary vascular 
changes in this new animal model strongly resembles the human pathology in the case 
of CDH, so our model provides many opportunities to study the problems of CDH and 
its pre and postnatal development. 
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Abstract 
THE NATURAL HISTORY OF 
CONGENITAL DIAPHRAGMATIC HERNIA AND 
PULMONARY HYPOPLASIA IN THE EMBRYO 
(J Pedia!r Surg 1993; 28:456-63) 
Up to now, descriptiollS of the natural history of congenital diaphragmatic hemia (CDH) 
associated with pulmonary hypoplasia (PH) are based exclusively on observatiollS lIlade in 
the fetal period. However, nothing is known about the evellls that take place in an embryo 
with CDH. Recently, an animal model of CDH and PH has been established in rat embryos 
to study the embryology and nahlral histOlY of this lesion. We exposed 36 pregnant 
Sprague-Dawley rats to a single dose of 100 mg nitrofen on day 11 of pregnancy. A total of 
356 staged embryos and fetuses from day 13 to day 21 were shldied by light and scanning 
electroll/llicroscopy. The litters of 9 untreated rats (124 nonllal age-matched embryos and 
fehlSes) served as controls. The abnonllal development of the diaphragmatic anlage wasfirst 
seen in embryos aged 13 to 14 days. A defect appeared in the dorsal part of the diaphragm, 
nonllally on the right side. The liver grew through this defect early a//. Gut was found in an 
intrathoracic position only ill the very late stages (day 21/22) alld lIewboms. Compared to 
call trois, lungs of lIitrofell-embryos with CDH were smaller, depending all the size of liver 
foulld ill the thoracic cavity. Histologically, compressioll of lung was absellt at these stages. 
Most authors speculate that CDH results because the pleuroperitolleal canals fai/to close 
at the end of the embryonic period (ie, week 8 to 10 in hUlIlall developmellt) leading to a 
defect ill the dorsolateral regioll of the diaphragm. However, contradictory to this assumption, 
our findings indicate that diaphragmatic defects develop in early embryonic life. They are 
easy to idelllify even ill rat embryos as early as 14 days. The early ingrowth of liver illlo the 
thoracic cavity through these defects is the crucial step ill the pathogellesis of PH ill CDR, 
because it is the liver alld not the glllthat reduces the thoracic cavity in the embryo. Nonllal 
IUllg growth will be hampered in early embryonic stages according to the size of the liver 
mass inside the thoracic cavity. Recent reports suggest that the presellce of liver in the fetal 
thoracic cavity affects the outcome of a fetus with CDH. This observation is in accordance 
with our filldillgs, suggesting that the major events of pathogenesis take place ill the embryo 
and 1I0t ill the fetus, as oftell assumed. 
Presellted at the 23rd Allnual Meeting of the Americall Surgical Association, Colorado 
SprillgS, Colorado, May 13-16, 1992. Supported ill part by ''Wemer Otto Stiftullg" 
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The outcome of a newborn with congenital diaphragmatic hernia (CDH) depends on the 
severity of the associated pulmonary hypoplasia (PH). Most authors consider lung 
hypoplasia as a secondary abnormality: delayed or incomplete closure of the so-called 
pleuroperitoneal canals may result in the herniation of intestine into the thoracic cavity 
leading to abnormal compression of the developing lungs[1,2]. Studies on the natural 
history of CDH in humans and data derived from experimental animal models[3-6] seem 
to support this assumption. These studies, however, are based exclusively on observations 
made in the fetal period while data that may elucidate the natural history of CDH in the 
embryonic period are not at hand. An animal model of CDH and PH has been recently 
established in rat embryos using nitrofen (2,4-dichloro-phenyl-p-nitrophenyl ether) as 
teratogen[7,8]. We used this model to define the specific morphological changes of CDH 
and PH during the embryogenesis of this lesion. 
MATERIALS AND METHODS 
Adult female Sprague-Dawley rats weighing between 196 and 319 g (mean, 261 g), were 
bred under normal laboratory conditions. After controlled overnight mating, pregnancy 
was verified by means of the vaginal smear method. The day of positive smear was rated 
as day zero of pregnancy. The pregnant rats were exposed to a single dose (100 mg/rat) 
of orally administered nitrofen (Wako Chemicals, Neuss, Germany) on day 11 of 
pregnancy. The substance was mixed with 20 g of moistened commercial rat chow 
(Altromin, Lage, Germany) and offered to the rats after a 24-hour period of fasting. Rats 
not consuming the mixture within 12 hours were excluded. Using this method, 36 
pregnant rats could be exposed successfully to nitrofen. There after the rats were again 
supplied with food and water ad libitum. Nine other rats, also undergoing a 24-hour fast, 
served as controls. Four rats from the nitrofen group plus one control rat were killed on 
each day between day 13 and 21 of pregnancy. A total of 480 embryos and fetuses (356 
from the nitrofen group, 124 controls) were removed by laparotomy and were then 
staged after Witschi[9]. One litter from each treated group and three embryos from each 
control rat (92 nitrofen embryos plus 27 control embryos) were fixed in Bouin, embedded 
in paraffin, cut in serial sections (7l'm), and stained with hematoxilin-eosin for light 
microscopy (LM). 
The remaining embryos and fetuses (264 nitrofen embryos and 97 control embryos) were 
fixed in glutaraldehyde for 24 hours and then microdissected in 80% ethanol. After 
dehydratation, the embryos were dried by critical point method, gold-sputtered, and then 
examined and photographed with a DMS 940 scanning electronmicroscope (SEM) (c. 
Zeiss, Oberkochen, Germany). 
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RESULTS 
SEM Findings 
In the first group (13 days) 30 nitrofen embryos and 5 embryos of the control group were 
studied. No deviation in the morphology of the diaphragm was found, when we compared 
the nitrofen group with the control group. Furthermore, we found no differences between 
the nitrofen group and the control animals when we studied the development of the 
lungs at this stage (Fig 1). 
In the second group (14 days) 41 nitrofen embryos and 4 controls were analyzed. In this 
age group there was clear evidence of disturbed diaphragmatic development in the 
embryos of the nitrofen group while evidence of disturbed lung development was absent. 
In the majority of these embryos, a defect was found in the dorsal part of the diaphragm 
(Fig 2A). All defects appeared exclusively on the right side. They resulted in an 
abnormal diaphragm, leaving parts of the liver uncovered. Compared to controls, the left 
dorsal diaphragm was found to be normal in all studied embryos. 
In the next two age groups (15 days and 16 days) 34 and 32 nitrofen embryos and 7 and 
6 age-matched controls were studied. In most litters, the majority of embryos had a right 
diaphragmatic defect. In all these embryos, the liver was clearly seen inside the thoracic 
Fig 1. SEM picture of a 13-day-old rat embryo; this stage correspoJlds to a IW11Iall embryo 5 weeks of age.("~ 
liver,' Sf, stomach,' LLu, left Illllg; RLu right IUllg).A) Dorsal view. 17le IUllgs are still ill situ. B) Dorsal view illto 
the thoracic cavity; the right IlIlIg is removed. Arrows illdicate tile lower border of 'he diapragm. 
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Fig 2 (A) SEM pictu,e 
of a 14 day-old 'at 
embryo (llitrofell group). 
Dorsal view. 11le lungs 
are removed. 11le left 
plellroperitollealopellilJg 
(/po) is 1I0nllal. A large 
defect is seell ill the 
nglJl diaphragm (black 
OffOWS). The diaphragm 
ends abnonnally highJ 
leaving pans of the liver 
IIlIcovered (B) SEM 
pichlre of a 13.S-day-old 
rat embryo (coJltrol 
group). Black a"oIYS 
indicate lire border 0/ 
the IlOn1Jally developed 
diaphragm White affOlYS 
indicate the site of this 
border i/l a 13-day-old 
embl)lo (white a"ows). 
TIle dowligrowth 0/ the 
diaphragm is lIotable. 
icvJ ill/eror vella cava. 
(11lis stage co"espollds 
to a hUlllon embryo 5 to 
6 weeks 0/ age) 
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Fig 3 /A) SEM picture 
of a 16-day-old Tal 
embryo (liitro/ell group). 
Lateral view. A small 
part 0/ the liver (Ii) 
protmdes diaphragmatic 
defect (di) alld is l/OW 
inside the thoracic 
cavity. Note lite close 
colltact betweell liver 
(Ii) alld IlIlIg (III). (B) 
SEM picture of a 
16-day-old rat embryo 
(nitrofell group). Dorsal 
view. 17le right Illllg is 
partially removed. 17le 
large defeci with tlte 
illtratltoracallydisplaced 
portioll of the lh'er (Ii) 
is seelJ. Due to the 
ingrowlh of liver, lite 
opellillg of tlte right 
pleuroperitoneal'callaJ" 
fails to close (a"ow). 
Note thaI this openillg 
represents ollly a small 
part of the whole defect. 
(Viis stage cOffespollds 
to a IlIlmall embl)'o 7 
lVeeks of age). 
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Fig 4. (A) SEM pichlre of a small diaphragmatic defecl. TYpically, these are ;/1 close conlact witllthe illferior 
vena cava (icv) alld are tJms mOTe cel/trally located. 11le white O"OW illdicates the regiolJ} where 'he openillg 
of 'he right pieuroperitOlJeal "cQllal" has closed. (B) SEAl picture of a {Olge diaphragmatic defect. This defect 
incorporates Ihe dorsolateral region (''Boclldalek·type'~. (11l/s stage corresponds fo a llIlmall embryo 8 weeks 
of age). 
cavity (Fig 3A). 1\vo distinct forms of the malformation could be discerned. Typically, 
a minor form of the defect was found centrally, close to the inferior vena cava (Fig 4A). 
In these cases the so-called pleuroperitoneal canals closed properly. In the major form 
(Fig 4B), the defect extended from the inferior vena cava to the dorsolateral region of 
the diaphragm, thus incorporating the openings of the pleuroperitoneal "canals". In these 
age groups, the gross aspect of the lungs appeared to be normal. The lungs often covered 
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Fig 5. SEM picture of a l8-day-old rat embryo (nitrofell group). View from dorsal. TI,e liver (Ii) ocmpies nearly 
one (hird of (he IIwracic cavil)'. 17,e right IUllg;s reduced ill size. Bowel/oops are absent (17,;s stage correspolJds 
(0 a human embryo 10 weeks of age). 
the diaphragmatic defect, making it difficult to detect. However, after removiug the 
lungs, the total extend of the defect became apparent (Fig 3B). In all normal 16·day-old 
embryos, the openings of the pleuroperitoneal "canals" were found to be closed on the 
right and left side of the diaphragm. At this stage, bowels loops were still found 
exclusively inside the extraembryonic celom of the umbilicus. 
In the following two age groups (17 days and 18 days) 28 and 25 nitrofen embryos were 
compared with 7 and 8 controls, respectively. 'There was a remarkable difference in the 
growth pattern of the more "central" defects (minor forms) and the "dorsolateral" defects 
(major forms). In some of the embryos with a major defect, the liver occupied one third 
of the thoracic cavity (Fig 5). In these cases, right lungs were markely reduced in size 
compared to normal controls. 
In the minor defects, only a small portion of the liver reached the thorax. In these cases, 
the lungs were near normal except for a small indention in the area of the protruding 
liver. In all 18·day embryos, the intestine was found inside the abdominal cavity while 
in the embryos of the 17·day age group, intestinal loops remained still in the 
extraembryonic celomic cavity of the umbilicus. 
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Fig 6. (A) SEM pichlre 
of 20-day-old rat fehls. 
Half of the thoracic 
cavity is occupied by 
liver (Ii). 17le IImg is 
markedly reduced. 
Bowel loops are still 
absellt (original maglli-
ficatioll x 20). (B) SEM 
picture of 21-day-old ral 
fetus (origillal maglli-
ficanoll x 8). 
Bowel loops (bl) filially 
IIave entered the tllora-
cic cavity. 17le liver (Ii) 
occupies two thirds of 
the t"oracic cavity. 17,e 
IlIlIg (Iu) is small. 
(17Jese stages corres-
pond to 11lIl1Iall fetllses 
older 111011 18 weeks). 
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Fig 7. LM piChlres of serial secl;ons of llJ.day-old rat embryos. (A) Control embryo. (B) NitrofelHmbryo 
(original magnification x 100). Clear s;grls of Illllg compressioll by the ingrowillg liver call IIOt be discemed. di, 
diaphragrll,' Ii, liver,. Ill, l"IIg, White affOW indicates the site of the diaphragrllatic defect. (11I;s stage co"espollds 
to a Imma" embryo 10 weeks of age). 
The next age groups (19 days, 20 days, and 21 days) represent the fetal stage of 
development. Here, the whole spectrum of the malformation could be observed. In some 
of the 19- and 20-day-old rat fetuses, over half of the chest was occupied by liver masses 
(Fig 6A), while in others the ingrowth of the liver was less obvious. In those with massive 
liver protrusion, the lungs were small and hypoplastic while they appeared near normal 
when only small parts of liver were found inside the chest. Intrathoracally displaced 
bowel loops were first observed in 21-day-old fetuses (Fig 6B). In these, the lungs were 
found to be reduced in size due to amount of liver occupying up to two thirds of the 
available thoracic space. 
LM Findings 
Our anatomical SEM findings were confirmed by serial histological sections. The defect 
was first identified in 1S-day-old embryos. It was always situated in the dorsal diaphragm 
and was found in close contact with the inferior vena cava. Starting on day 16, the liver 
gradually expanded into the thoracic cavity. However, clear signs of lung compression 
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were not found in our embryos (Fig 7). Comparison of the lungs and the thoracic cavities 
in age groups 16 and 18 demonstrated that in the embryo, these structures were 
expanding despite the ingrowth of liver (Fig 8). 
DISCUSSION 
Since Broman's investigations(10) on the diaphragmatic development, most authors have 
speculated that CDH results because the pleuroperitoneal canals fail to close at the end 
of the embryonic period (ie, week 8 to 10 in human development) leading to a defect in 
the dorsolateral region of the diaphragm[l,2,l1). Bowel loops may then herniate through 
this defect into the chest with subsequent hypoplasia ofthe developing fetallungs[l,2,l1). 
However, the natural history of this sequence of embryological and fetal events has not 
been previously studied. Thus, the pathogenesis of the CDH and the associated PH is 
still elusive and the answers to the following questions remain unknown: (1) When does 
the diaphragmatic defect appear? (2) Are the pleuroperitoneal canals the precursors of 
the diaphragmatic defect? (3) Why is the lung hypoplastic in cases of CDH? 
Since 1971, the embryotoxicity of the herbicide nitrofen (2,4 - dichloro - phenyl - p -
nitrophenyl ether) is well known(12). In 1981, Nakao et al(13) noticed that this teratogen 
can induce CDH in rats and mice. Since then, this substance 
has been widely used to study its effect on the lung and diaphragm[14-16). However, only 
the work of Iritani[ 16) adresses the natural history of CDH in the embryo. In our study, 
we used the pulse feeding technique. Pregnant rats were exposed to a single 100-mg dose 
of nltrofen on day 11 of pregnancy. This day has been previously identified by us to be 
highly sensitive to the teratogenetic effect of nitrofen[7,8). 
The Onset of CDH 
Most authors speculate that in the human fetus with CDH, the pleuroperitoneal canals 
fails to close late in the embryonic period between the 8th and 10th week of 
gestation[1,2,ll). At the same time, the intestine returns into the abdominal 
cavity[l,2,11,17). In rats, this developmental stage is equivalent to that of 17 or 18 days 
of gestation. At this time, the openings of the so-called pleuroperitoneal canals are 
normally closed(18) 
In contrast to this assumption, it is evident from our study that the diaphragm is already 
malformed in the 14-day-old embryo (Fig 2A). This age group is equivalent to that of a 
5- to 6-week-old human embryo. In a 13-day-old rat embryo, signs of a disturbed 
diaphragmatic development are still missing (Fig 1B). However, the onset of the 
malformation takes place at this stage. The diaphragmatic anlage of a 13.5-day-old 
embryo (Fig 2B) is too advanced to serve as the starting point for the maldevelopment. 
These findings are in accordance with observations made by Iritani(16). He found signs 
of disturbed diaphragmatic development in 11-day-old mouse embryos exposed to 
nitrofen continuously from day 5 to 11 after conception. Thus, we conclude that in rat 
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embryos the onset of the diaphragmatic defect clearly lies in the early embryonic period. 
This phase is comparable to that of a human embryo in the 5th gestational week. 
The Site of the Defect 
Iritani[16] was the first to notice that nitrofen induced diaphragmatic hernias are not 
caused by an improper closure of the pleuroperitoneal openings but rather the result of 
a defective development of the so-called posthepatic mesenchymal plate (PHMP). The 
observed defects were also localized in the PRMP in our SEM study (Fig 2A). We could 
identifY two distinct types of defects: (1) large "dorsolateral" defects and (2) small 
"central" defects. Large defects extended into the region of the pleuroperitoneal 
openings. In these cases, the closure of the pleuroperitoneal openings was usually 
impaired by the massive ingrowth of liver (Fig 3B). If the defects were small, they were 
consistantly isolated from the pleuroperitoneal openings closing normally at the 16th or 
17th day of gestation. Thus, in our embryos with CDR, the region of the diaphragmatic 
defect was a distinct entity and was seperated from that part of the diaphragm where the 
pleuroperitoneal "canals" are localized. We conclude therefore that the pleuroperitoneal 
openings are not the precursors of the diaphragmatic defect. 
The Lung in CDR 
Primary pulmonary hypoplasia, 
Nakao et al[14], Ueki et al[15], and Iritani[16] postulated that the lung is primarily 
hypoplastic. In his study, Iritani even drew the conclusion that the hypoplastic lung may 
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induce a defective PHMP which may again result in CDH[16]. 
However, in our young embryos (14 days gestational age) with a diaphragmatic defect, 
disorders of the early lung anlage could not be observed. This finding is in sharp contrast 
to previously published results by Ueld et al[15]. They observed reduced lung growth in 
young mouse embryos continuously exposed to nltrofen from postconceptual days 5 to 
11. However, this reduced lung growth may be the result of nitrofen interference with 
the very early lung anlage. It is well known that developing embryonic organs have 
specific periods of greatest sensitivity to teratogens. Continuous administration of 
nitrofen for a longer period must thus result in an combination of malformations. In our 
study, we avoided this combination by pulse feeding of nitro fen on day 11. The 
diaphragm has proved to be highly sensitive to the teratogenetic action of nltrofen on 
this day[7,8]. 
Secondary pulmonary hypoplasia. 
It is generally assumed in the literature, that lung hypoplasia in cases of CDH is of 
secondary origin[1,2,4,5,l1] and that this hypoplasia is caused by herniated bowel loops 
compressing the developing fetal lung[l1]. In contrast to this assumption, our study 
indicates that pulmonary hypoplasia develops in the embryonic period. Soon after the 
onset of the defect in the 14-day-old embryo, liver grows through the diaphragmatic 
defect into the thoracic cavity. This indicates that from this time on the available thoracic 
space is reduced and further lung growth hampered. In 15- or 16-day-old embryos, the 
amount of liver inside the chest is only small (Fig 3A). Therefore, the lungs are nearly 
normal in these age groups. However, in embryos aged 17 or 18 days, more than one 
third of available thoracic space may be occupied by liver masses. In these cases, the 
impaired lung growth is obvious. At first sight, in our embryos PH seems to be the result 
of compression caused by the ingrowing liver. However, serial section analysis shows that 
clear signs of lung compression are absent (Fig 7). Furthermore, it is obvious (Fig 8) that 
in the embryo, the thoracic cavity expands despite the ingrowth of liver. Lung 
compression is therefore unlikely in a fast growing embryo. 
Herniated gut was found in our embryos and fetuses only in late stages of development 
(21 days and newborns). In all of these, the lungs were already hypoplastic, when the 
bowel entered the thoracic cavity (Fig 6B). Based on our observations, we conclude that 
the early ingrowth of the liver through the diaphragmatic defect is the crucial step in the 
pathogenesis of PH in CDH. The presence of liver inside the fetal thoracic cavity was 
recently comidered to be of major prognostic importance in the outcome of a fetus with 
CDH[19]. Our pathogenetic concept clearly explains this observation. We found that 
impaired lung development is proportional to the size of the liver mass imide the 
thoracic cavity. This indicates that growth impairment is not the result of lung 
compression in the fetus but rather the result of growth competition in the embryo: the 
liver that grows faster than the lung reduces the aviable thoracic space. If the remaining 
space is too small, PH will result. 
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Abstract 
NITROFEN INDUCED DIAPHRAGMATIC HERNIA: 
PRESSURE-VOLUME REGISTRATION AND 
ARTIFICIAL VENTILATION IN NEWBORN RATS 
(accepted for publication) 
Congenital diaphragmatic hemia (CDH) can be introduced in rat fetuses by administering 
the herbicide nitrofen to pregnant rats. 
Artificial ventilation of newborn rats with intenllittent registration of pressure-volume (P-V) 
diagrams is described. The first experiment shows that delivery of the fetus by hysterotomy 
is followed by inadequate ventilation duni.g the first hour after delivery (p <5%; hysterotomy 
vs spontaneous delivery). This delayed lung adaptation is characterized by impaired 
compliance values. 
In the second experiment lung mechanics and histology were compared immediately after 
spontaneous birth (0 h) and after 1 and 6 hours postpartum in controls (C), and nitrofen 
exposed animals with (NH) or without (NN) CDH. The differences between the C and NH 
groups considering the volumes during all points of measurement (0, 1, 6 hours) are 
significant. For example: at P=10 cm H,D, the corresponding volumes (0, 1, 6 hours) for 
Care 137 ±. 92; 189 ±. 33; 301 ±. 93 IJI and for NH are 17 ±. 28; 75 ±. 73; 147 ±. 78 IJI. 
The mortality ill the NH group with postmortem provell severe CDH was high; 80% did 1I0t 
survive the 6 hour period. Because the mortality rate in the less affected NH group was lower 
(35%), the NH group showed a paradoxical improvement ill time due to a relative increase 
during time of the better pe/fonning, less affected CDH. 
Conc/usion: newborn rats can be ventilated for several hours. Since improvement in lung 
function induced by, e.g. drugs, will result ,i. altered P-V relations, this model is suitable for 
testing new modes of treatment during the period immediately after birth. 
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Congenital diaphragmatic hernia (CDH) remains a major problem in neonatology and 
pediatric surgery. The reported incidence of this anomaly ranges from 1 in 2200 to 1 in 
SOOO births [1·3J. 
Even today, mortality of patients with CDH remains over 40% as a result of pulmonary 
hypoplasia with or without pulmonary hypertension. Infants with severe respiratory 
distress need maximal ventilatory support and are often subjected to high inflation 
pressures and high percentages of oxygen. The side effects of prolonged respiratory 
treatment are well known [4J and the clinical picture of bronchopulmonary dysplasia is 
increasingly encountered in neonatal intensive care units [SJ. 
The enormous variety in presentation of CDH, from minimal respiratory symptoms in 
the days to years following birth to severe acidosis and hypercarbia accompanied by 
acute pulmonary hypertension immediately after birth, makes it difficult to evaluate the 
efficacy of new therapeutic techniques. The evaluation of these techniques, such as 
delayed surgery, extracorporeal membrane oxygenation (ECMO), high frequency 
oscillation ventilation (HFOV) and surfactant replacement therapy [6·9J is further 
impaired by the effects of the necessary aggressive and often combined procedures to 
overcome acute respiratory insufficiency. Improvement of therapies for CDH patients 
with respiratory distress requires not oniy insight into normal and abnormal pulmonary 
development such as morphology and biochemistry, but also the effect of ventilation on 
these parameters. 
In a fetal rat model, CDH and subsequent pulmonary hypoplasia is induced by 
application of 2,4 dichlorophenyl.P.nitrophenyl ether(nitrofen) at day 10 of gestation 
[10,11J. 
Until now there are few reports in the literature on artificial ventilation of newborn [12J, 
or premature born [13J rats. TIle chosen method for ventilating the rats in the present 
study was first described by Lachmann et a!. [14J for the ventilation of neonatal rabbits. 
The purpose of this communication is to provide basic information on ventilation of 
small rats, and to demonstrate the effects on lung mechanics in the neonatal rat with or 
without CDH during artificial ventilation. 
MATERIALS AND METHODS 
Animals 
All experiments were approved by the Animal Ethical Committee of the Erasmus 
University Rotterdam. Female Sprague Dawley rats (Harlan, Zeist) weighing 240·280 
grams were mated during 1 hour; this time was considered as day 0 of gestation. On day 
1O.S of gestation lIS mg nitrofen dissolved in 1 ml oil, was administered by gastric tube 
to the nitrofen (N) group; controls received 1 ml oil as described before [lOJ. Normal 
gestation in these rats lasts about 22 days. We either performed a hysterotomy at 
gestational day 22 or awaited spontaneous birth (most animals were delivered at mean 
22.2 days); animals with unknown time of spontaneous birth were excluded from the 
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experiment. 
Three groups of newborns were recognized: Controls (C); nitrofen exposure without 
resulting diaphragmatic defect (NN) and with diaphragmatic hernia (NH). It was not 
possible to sort the NN and NH animals immediately after delivery, since the dams 
treated with nitrofen delivered both. 
Preparation 
For the hysterotomy the dam was killed by an intraperitoneal injection of sodium 
pentobarbital (250 mg/kg) and the fetuses were delivered. 
Immediately after birth or hysterotomy, the newborns were weighed and received 
pentobarbital (20 mg/kg every 3 hours) and pancuronium bromide (0.08 mg/kg every 
hour) intraperitoneally. In a pilot study we found a clear time saving in favour of 
intubation versus tracheostomy (2 min vs 5 min) while no influence on ventilation 
parameters was observed. 
The animals were intubated with a metal canula. The canulas used throughout the 
experiment were made from syringe needles (internal diameter 0.5 mm; external 
diameter 0.7 mm); after intubation the canula was fixed to the animal's head by a strip 
of plaster. The intubated animals were immediately transferred to a multichambered, 
pressure-constant body plethysmograph heated to 38°c' The connection with the 
bodybox was performed by a flexible tube to provide an adequate connection between 
the trachea and the bodybox. The maximum number of ventilated animals per litter was 
9. The NN/NH determination was made after autopsy. 
Lung weights were only determined after birth before ventilation, and were compared 
with the values found in former studies [10]. 
Experimental set-up 
In the first experiment, lung mechanics were compared between spontaneous born rats 
and those delivered by hysterotomy. Measurements were made immediately after birth 
or delivery and after 6 hours ventilation. 
The second experiment included only spontaneous born animals. These animals were 
ventilated for maximal 6 hours. Pressure-volume relations were determined at 0, 1 and 
6 hours. Zero-hour animals were intubated immediately after delivery before any sign 
of spontaneous breathing. If any sign of spontaneous breathing was visible, the animal 
was excluded from this group. Animals without visible heart action, pneumothorax or 
other complications related to insufficient ventilation were also excluded from the study. 
After the experiment the animals were killed by an overdose of pentobarbital before 
preparation of the lungs. 
Due to the use of some animals for histology and the death of several others (mainly 
from the large-sized [10] CDH group) during measurement, the composition of the 
groups varied in time. 
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Ventilation 
The body plethysmograph was connected to a ventilator (Servo 900B, Siemens Elema 
Sweden) as described by Lachmann [14]. This equipment provides pressure-generated 
ventilation with decelerating flow using excess flow through the ventilator system. 
The ventilator settings throughout the experiment were Fi02 1.0; frequency 40/min; I/E 
ratio 1:2; peak pressure 17 em Hp; PEEP = 0 em Hp. 
At 0, 1, and 6 hours, the pressures were varied from 6 em H20 to maximal 28 em H20 
and back to 6 em Hp by steps of approximately 5 em Hp; the other ventilator settings 
remained unchanged. Volumes were determined with a specially designed Fleisch-tube 
[14] connected to the body plethysmograph, a differential pressure transducer (Siemens 
Elema EMT 34), amplifier (EMT 31), and integrator unit (EMT41). Airway pressure was 
measured by means of a pressure transducer; P-V data were recorded simultaneously 
(Siemens-Elema Mingograph 81). 
Heart action was controlled visually, because it was not possible to have reliable ECG 
tracings in the bodybox. 
Histology 
All lungs used for histology were fixed in situ; a part was prepared as reported previously 
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by inflation of the lungs during fixation with Davidson solution [15J, or by fixing them for 
several days by submerging the unopened thorax in Davidson solution. Routine histologic 
preparation (6 I'm slides; HE staining) was followed by microscopic examination with 
particular reference to expansion pattern, hemorrhage, interstitial emphysema, 
inflammation, and other lesions that may have influenced lung mechanics. 
Calculations and statistical analysis 
By means of the measured P-V points, an inflating and deflating limb (PV-curve) was 
plotted for each animal at the specified times. 
For the deflation limb of individual P-V curves the volumes (in 1'1) at the standardized 
pressures 0, 6, 10, 15, 20 and 25 cm H20 were determined. 
From the expiratory limbs of the P-V curves two other parameters were calculated: 
1. Compliance at 15 cm H20 (mi/cm H20) 
2. Compliance normalized for body weight at 15 cm H,o (mI/cm H,o/kg bw) 
In each group (C, NN, NH), at the mentioned time (0, 1, 6 hours), a mean volume and 
derived parameter was calculated. TIlis enabled to compare the measured volumes and 
their derivatives in all groups at a certain pressure. 
Comparison of the differences between the groups and their statistical significance were 
determined by means of T-test or analysis of variance (data were normally distributed). 
TIle P-values are indicated. 
RESULTS 
The body weights (4-6 g) and lung weights in this experiment correspond well with those 
reported in an earlier study [10J. 
First experiment 
We considered the first experiment as a pilot study to establish differences between 
spontaneous born and hysterotomy delivered rats (controls and CDH rats). Several 
animals were lost because they were born at times when it was impossible to start 
measurements immediately. 
Spontaneous born rats (Span); CSpon (n=9) and NHSpon (n=8), and rats delivered by 
hysterotomy (Hyst); CHyst (n=9) and NHHyst (n=7) were compared at T=Oh and T=6 
h. At T = ° h there was a significant difference in P-V relations between CSpon and the 
three other groups. At P = 15 cm H20, the volumes of CSpon, CHyst, NHSpon and 
NHHyst were 210, 30,.40 and 40 1'1, respectively. (Fig. 1; P < 1 %). After 6 hours 
ventilation no significant difference was found between the control animals born 
spontaneously or obtained after hysterotomy. Because of this observed distinction in the 
control group, we decided to use only spontaneous born animals with known time of 
birth for the second experiment. 
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Second experiment 
All animals were delivered spontaneously, intubated immediately and P-V measurements 
were made (Fig. 2). The total number of animals in each group is given in Table 1. In 
the NH groups left and right-sided CDH are present; their numbers are not specified. 
The size of the hernias were comparable at 0 hand 1 h: 70% was defined as "large 
dorsal", the remaining 30% as "medium dorsal", although marked differences in 
mechanical hehaviour between the same type of hernia were observed. 
Table 1. 
Hours 
o 
1 
6 
C 
23 
28 
30 
NN 
22 
20 
31 
NH 
15 
31 
14 
Numbers o/llewbom Tats lised durillg the second experimellt. C "" COlltrol,. NN = Nitro/ell without CDR,. NR 
"" Nitro/ell witll CDH. Numbers indicate allimals used JOT obtaillillg P-V values. 
The mortality in the NH group with postmortem proven severe CDH (coinciding with 
very low volumes) was higher: almost 80% did not survive the 6 hour period. In the less 
severe affected CDH this was about 30-40%, against 5% and 7% in the C and NN group, 
respectively. These mortality rates included the deaths after T=O due to technical 
problems such as plugged canula or missed (re)-intubation. 
After intubation and starting ventilation, the NH group showed almost no lung 
expansion, there was only a slowly change in colour of the fetus from blue to pink. In the 
C group this colour change was performed within two breaths, while in the NN group 6 
animals had a similar colour change pattern as in the NH group. This small group of 6 
animals is outnumbered by the other 16 animals from which several performed better 
than the controls. 
Volumes 
(See also Fig 3). At T=O the NH group (n=15) has significantly lower volumes at 
matched pressures than the NN (n=22) and C (n=23) (p<I%). 
At T= 1 and T=6 the difference between the NN and NH groups has almost 
disappeared, but both still show a significant difference compared to C (p < 1 %). 
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'3. 
-
41 
E 
:::I 
'0 
>-
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left ads. 17le CDH IUlig sholYs 110 stabilisation of Ihe ainvays, resulting ill higll i,,/lalioll preSSllres for small 
changes ill volume; and a drop almost to zero al ratller higll expiratory pressf/res. 
Compliance 
Compliance and compliance normalized for body weight are significantly (p < 1 %) lower 
in the CDH rats. The body weight does not influence the compliance significantly. 
Histology 
Lungs obtained at T= 0, 1 and 6 hours ventilation, were examined. The lungs of CDH 
rats, irrespective at which hour they are examined, show very poor saccular air expansion, 
i.e. the appearance of most terminal air spaces corresponds to the fetal, fluid-filled state. 
There is almost no stabilization of the smaller airways. Instead, the thick-walled, densely 
compacted cells dominate the view (Fig. 4b). Even in the full-term born control and NN 
animals after 6 hours ventilation, aeration of the lungs was generally incomplete and 
irregular (Fig. 4a). In all groups, intrasaccular hemorrhage of varying degree was 
observed in most lungs, but there were no widespread hemorrhagic lesions. There were 
also clear signs of interstitial emphysema and, in a few cases, also interstitial edema. 
30 
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DISCUSSION 
In the present study, changes in lung mechanics due to induced CDH are evaluated. The 
results of the first experiment showed the effect of the passage through the birth canal 
on the first breaths and after 6 hours of ventilation. After 6 hours no significant 
differences were seen between the animals obtained by hysterotomy and those born 
spontaneously in the same group. The difference found between CSpon and NHSpon at 
T=O h was not observed between CHyst and NHHyst (p<1%). To provide adequate 
aeration of the liquid filled lung at birth, the insufflation pressure must be high enough 
to overcome capillarity in the finer conducting airways [16]. This opening pressure must 
be applied for a period long enough to overcome the viscosity of the fluid in the larger 
airways because the air-liquid interface is not founded in these larger airways and a 
considerable extra volume has to be absorbed by the saccules. Another important 
characteristic is to establish the functional residual capacity (FRC); this is organized 
quickly after birth and is slowed in hysterotomized animals [17]. Because of the result 
of the first experiment; a negatively influenced establishing of FRC due to hysterotomy, 
we decided to use spontaneous born animals for the second experiment. 
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Figure 3. Mea" volumes calclliated from the individual expiratory loops at pressure 10 cm H20 (30) and 25 
cm H20 (3b) during the si'(-hollr study. The horizollfal aus represellls the lime (It), Ihe correspondilJg volume 
(ill pi) and standard deviatioll is sliown 011 the ~'ertical axis. l7IFee different groups C (left bar, dark area), NN 
(middle bar. dellSe striped area), and NH (riglJt bar. light striped area) are showli . 
• = significant from COJJiTol at tlte same time 
# = significant from nitro/ell at the same time 
+ = SI'glJijiCOllt from same group at T=O h 
& = sigtJijicallt from same group at T=l h 
pressure·volume registrations 84 
Figure 4. COllfrollllllg (lefl) alld NH Illllg (right) both w/ltilated for 6 hOllrs. Same original magnificatioll (2.5 
.~), HE staining after DaYidson {aatioJl {lS}. 
The results of the second experiment show the CDH rat model is suitable to evaluate 
different ventilatory regimens. Rats weighing 4-6 g can be intubated and ventilated for 
several hours. The mortality rate of about 80% in the very severe CDH group 
corresponds with the human situation [1,10]. Death is caused by pneumothorax, severe 
ventilatory insufficiency or pulmonary hypertension. This significantly influenced the 
results of our experiments after 6 hours. Careful examination of the data obtained in the 
second experiment suggests that an unforeseen natural selection took place in time; the 
NH survivors at t=6 h already showed at t=O h, and 1 h better PV-relations than the 
mean value of the group (p<5%). This could explain the gradual improvement in the 
NH group during the experiment. It may also be concluded that (as in the human 
situation) the very severe CDH animals die within 6 hours after birth, irrespective of 
their treatment. This important result has to be considered in future experiments. 
It is well established that artificial ventilation influences normal cardiovascular and 
respiratory function [18]. Moreover, an important factor is that ventilation itself can lead 
to decreased lung compliance and dysfunction of gas exchange; the underlying causes are 
formation of atelectasis, pulmonary edema and interstitial emphysema [19]. To date, no 
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adequate explanation of the pathophysiological basis of all these changes due to artificial 
ventilation has been documented. However, there is evidence that in at least a part of 
these alterations, the surfactant system is involved [20J. The recording of pressure-volume 
(P-V) diagrams is the only direct in vivo test for characterization and indication of 
damage to the surfactant system and lung function [14,20J. 
Reports on the surfactant system and its function in CDH lungs in humans are scarce; 
they only show the lecithin/sphingomyelin ratio, which is an inaccurate method of testing 
surfactant function. This ratio was reported to be lowered [21J or unchanged [22]. 
In the present set of experiments, the ventilatory settings were kept constant because we 
were only interested in the effect of ventilation on CDH mechanics in our rat model; the 
influence of different ventilatory settings in our model are subject of later studies. It is 
demonstrated that the presence of CDIt is associated with decreased total lung capacity 
(lie) and compliance, as was also found in the lamb model [23-25J. It can be expected 
that the total lung volume will be proportional decreased, but there has to be other 
contributing factors, so the enormous reduction in liC can only partly be explained by 
relating it to pulmonary hypoplasia. Pringle et al [26J suggested three possible factors 
based on lamb studies: first, a failure of development of the respiratory surfaces; second, 
the increased thickness of the barrier to gaseous exchange; and third pulmonary 
hypertension. The presumed surfactant deficiency has an important role [25J, it is 
suggested to have an increased inhibitory effect of the alveolar proteins on surfactant 
function; on the other hand a decreased production of surfactant. 
In the rat model a retarded differentiation of cuboid type II into squamous type I cells 
has been reprted, as well as morphometric proven smaller lung volumes and lung tissue 
volumes, smaller airspace/tissue ratios, and smaller epithelial surface areas [27,28J. Suen 
et al [29J found a lower amount of total disaturated phosphatidylcholine (DSPe) per mg 
lung and per I'g DNA in the rat model. 
Another indication for involvement of the surfactant system is found in the low 
compliance of CDH lungs in the present study. The airways are not stabilized during 
deflation so they tend to collapse, resulting in high inflation pressures throughout the 
experiment. 
The NN group shows the same intermediate position as in the RSC study [lOJ, suggesting 
a sliding scale from healthy lung to CDH. This implies new evidence to the theory that 
the lung is primarily affected and that the defect diaphragm is perhaps secondary to this 
anomaly. 
In conclusion, the results of this study demonstrated the rat model to be an effective tool 
in CDH research for functional test of drugs or ventilatory effects. 
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Abstract 
EVALUATION OF LUNG FUNCTION CHANGES 
BEFORE AND AFTER SURFACTANT APPLICATION 
DURING ARTIFICIAL VENTILATION IN NEWBORN RATS 
WITH CONGENITAL DIAPHRAGMATIC HERNIA 
(J Pediatr Surg 1994; 29:820-824) 
Patients with congenital diaphragmatic hemia (CDH) have unilateral or bilateral hypoplasia 
of the lungs including delayed maturation of the tenninal air sacs. Because these lungs are 
highly susceptible to barotrauma and oxygm toxicity, even in full-tenn newborns, continued 
research into optimal ventilatory regimen is essential to improve survival rate and to prevent 
ongoing lung damage. Against this background, the effect of exogenous su!factant application 
is evaluated. In newbom rats, CDH was induced after a single dose of 2,4 
dichloro-4'-nitrophenyl (Nitrofen) (400 mg/kg) on day 10 of gestation. The newborn rats 
lVere intubated immediately after hysterotomy, trallSferred to a heated multichambered body 
plethysmograph, and artificially ventilated. Inspiratory peak pressures lVere initially set at 17 
cm H,O, lVith positive end-expiratory pressure at a cm H,o and FiO, at 1.0. The pressure 
lVas raised in steps of 5 cm H,o, from 5 to 30 cm H,o, to obtain pressure-volume diagrams 
at 0, 1, and 6 hours of artifical ventilation. These measurements lVere obtained in controls 
and in CDH rats lVith and lVithout endotracheal instal/ation of bovine swfactant (n = 4 to 
10 in each group). Significant differences in lung volume between CDH and control rats lVere 
observed at all time-points. Su!factant application had a positive effect on lung volume, 
especially in control rats at t = 1 hour. No significant differences lVere observed between the 
CDH groups at t = 1 or t = 6 hours. In this animal model, the effect of artificial ventilation 
as lVell as the beneficial short-temt effect of exogenous su!factant application have been 
evaluated. A continued positive effect on lung volume in CDH lungs could not be 
detennined. Routine administration of exogenous su!factant in human CDH patients is not 
supported by these experimental results. 
Supported by the Sophia Foundation for Scientific Research and the Dutch Astma 
Foundation. 
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In patients who have congenital diaphragmatic hernia (CD H), abnormal morphological 
development of both lungs and the intrapulmonary blood vessels is present[I-5]. 
However, reports on the biochemical maturation of the lung in CDH are scarce. 
Hisanaga et al[6] noted low lecithin:sphingomyelin ratios (0.56 and 0.57, respectively) in 
two iufants with CDH. They argued that lung hypoplasia actually means a reduced 
number of type II pneumocytes and reduced production of surfactant. The 
lecithin:sphingomyelin ratio reflects to some extent the maturation of the fetal lung. 
However, the question remains: are the ratios low because of the total reduction in lung 
tissue or because the type II cell in CDH functions at a lower level[7]? 
Hashimoto et al[8] investigated the morphological characteristics of the type II cell in a 
fetal lamb model of CDR. Surprisingly, they found that type II cells were 5 to 10 times 
more abundant in the lungs of animals with a diaphragmatic defect. No ultrastructural 
changes of immaturity were observed in type II cells. 
Glick et al[9] studied lung surfactant production in the fetal lamb after experimental 
induction of CDH and showed (1) a marked decrease in pulmonary compliance, (2) a 
reduction of the total amount of phospholipid in bronchoalveolar lavage fluid, and (3) 
a reduction in the synthesis rate of phosphatidylcholine by type II cells. The authors 
concluded that CDH in the fetal lamb leads to profound lung hypoplasia and apparent 
immaturity of the surfactant system. 
In neonatal rats, CDH can be induced by feeding of 2,4 dichloro-4' -nitrophenyl ether 
(Nitrofen, Rohm & Haas Co, Philadelphia, PA) to the mothers during gestation, as 
documented previously[1O-12]. In this model, the lungs of CDH animals showed 
hypoplasia and lower content of disaturated phosphatidylcholine per microgram DNA 
and total disaturated phosphatidylcholine, as shown by Suen[13] . 
. The conflicting results obtained in different animal models has guided us to investigate 
the effect of exogenous surfactant application in relation to changes in lung volume after 
artificial ventilation in newborn rats with CDH. 
MATERIALS AND METHODS 
Female Sprague Dawley rats (Harlan, Zeist, The Netherlands) weighing 240 to 280 g 
were mated during 1 hour (day 0 of gestation). On day 10 of gestation, 100 mg of 2,4 
dichloro-4' -nitrophenyl ether (Nitrofen), dissolved in 1 ml of olive oil, was administered 
by gastric tube to the Nitrofen group; controls received 1 ml of olive oil. Food and water 
were supplied ad libitum during the entire period. Hysterotomy was performed on 
gestational day 22. 
The animals born spontaneously were excluded from the experiment because the period 
of spontaneous breathing could not be determined in detail and would influence lung 
function parameters. There were three groups of newborns: controls, animals with a 
diaphragmatic hernia, and animals without a diaphragmatic defect after Nitrofen 
administration (10%-20% of the animals receiving Nitrofen). 
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Before the hysterotomy, the dam was anaesthetized with N20 and enflurane-inhalation, 
and the fetuses were delivered. Immediately after hysterotomy, the newborns were 
weighed and received pancuronium bromide (0.08 mg/kg .each second hour) and 
pentobarbital (40 mg/kg each third hour) intraperitoneally, followed by intnbation with 
a metal canula. The cannulas used throughout the experiment were made from syringe 
needles (internal diameter, O.S mm; external diameter, 0.7 mm). 
The intubated animals were immediately transferred to a multichambered, 
pressure-constant body plethysmograph heated to 38 o C. This procedure lasted 1 to 2 
minutes for each animal. A flexible tube provided an adequate connection between the 
trachea and the body-box. The maximum number of ventilated animals per litter was 
nine. 
Artificial Ventilation 
The body plethysmograph was connected to a modified ventilator (Servo 900B; 
Siemens-Elema, Solna, Sweden), as routinely used in the I.C.u., and as described by 
Lachmann et al[14]. This equipment provides pressure-generated ventilation with 
decelerating flow, using excess flow through the ventilator system. 
The ventilator settings throughout the experiment were as follows: Fi02, 1.0; frequency, 
40/min; I:E ratio, 1:2; inspiratory peak pressure, 17 em H20; positive end-expiratory 
pressure (PEEP), ° em. These settings were changed only to obtain pressure-volume 
relations, ie, the pressures were raised from 7 em H20, in steps of approximately S em 
H20, to a maximum of 30 em H20. The other settings remained the same throughout 
the experiments. The pressure-volume relations were determined for each fetus with a 
specially designed Fleisch-tube[14] connected to the body plethysmograph, a differential 
pressure transducer (EMT 34; (Siemens Elema) and amplifier (EMT 31), an integrator 
unit (EMT 41), and a recorder Mingograf 81; Siemens-Elema). 
The animals were ventilated for a maximum of 6 hours. Pressure-volume relations were 
determined at 0, 1, and 6 hours. Zero hours applied to the animals that were intuhated 
immediately after hysterotomy because they showed no signs of spontaneous breathing. 
The animals without visible heart action, pneumothorax, or other complications related 
to insufficient ventilation or technical problems were excluded from the study. The same 
holds true for animals without CDH after Nitrofen administration and those with huge 
diaphragmatic defects that died less than 6 hours after birth. After the experiments, the 
animals were killed by an overdose of pentobarbital. 
Surfactant Application 
After intubation and the start of artificial ventilation (with peak inspiratory pressures of 
17 em H20, PEEP of ° em H20, and Fi02 of 1.0), both control and Nitrofen animals 
received either a bolus of bovine surfactant (O.OS mI of a 2S-mg/m1 solution) or nothing. 
Pressure-volume diagrams were obtained as described before, at t = 1 and t = 6 hours. 
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Calculations 
By means of the measured pressure-volume points, a pressure-volume curve was plotted 
for each animal at each time-point. The volume at the standardized pressures of 7, 10, 
15, 20, 25, and 30 em H 20 was determined from these curves and recorded. For each 
group, the means of volume were calculated at standardized pressures. These means 
were compared, and statistical significance was determined by means of the 
Mann-Whitney or Student's t test. 
RESULTS 
For each group, the values of lung volume at the peak pressures of 15 and 25 em H2O 
(with standard deviation) as well as the number of animals at each time-point are shown 
in Table 1. 
Table 1. Pressure/Volume Relations 
Control 
TIme No Surfactant 
(hoUls) 15cmH1O 25emH1O 
0 Mean 24.8 81.4 
SO 17.6 32.1 
" 
16 
Significance 
Mean 109.8 160.4 
SO 34.9 41.1 
" 
9 
Significance @ @ 
6 Mean 141.3 165.1 
SO 50.8 63.3 
" • Si9nificance @ @ 
HernIa 
TIme NoSurfactant 
(hours) 15emHj O 25em HIO 
0 Mean 5.9 22.4 
SO 5.6 23.6 
" 
9 
SJgn'ificance # # 
Mean 34.1 95.3 
SO 13.9 38.2 
" 
6 
Significance @# @# 
6 Mean 41.6 87.8 
SO 27.3 25.3 
" 
6 
SIgnificance @# @# 
Note. For all values, p<5%. 
Abbre~'iat;oJls: @, sigm'/icalll from T=O ill the same group,' 
., SiWlificQllt from the same grOIlP witholll surfactalll,' 
#, siWlijicallt from control at the same time. 
Surfactant 
15 em HjO 25em HIO 
108.6 216.9 
59.2 61.9 
12 
@ @. 
146.5 190.4 
45.9 61.5 
10 
@ @ 
Surfactant 
15cmH1O 25 emH10 
26.9 83.5 
17.1 20.6 
6 
@# @# 
44.9 85.6 
30.4 38.6 
4 
@# @# 
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Representative pressure-volume diagrams are shown in Figs 1 and 2. There are 
significant differences for each time-point between control and CDH rats, with CDH rats 
having lower lung volumes. The effect of surfactant application is greater in controls than 
in CDH rats. A positive effect of surfactant application in control rats was found at t = 
1 hour. There were no significant differences at t = 1 or t = 6 hours between the CDH 
groups. 
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DISCUSSION 
Animal Data 
Our study shows not only that artificial ventilation of neonatal rats is possible but also 
that the effect of exogenous surfactant application can be studied in detail. Following the 
classic approach of inducing CDH in sheep (by Harrison et al[15]), Hashimoto et al [18] 
investigated the morphological characteristics of the type II cell in a fetal lamb model 
of CDH. Surprisingly, they found that type II cells were 5 to 10 times more abundant in 
the lungs of animals having a diaphragmatic defect. No ultrastructural changes of 
immaturity were observed in type II cells. 
In contrast to the above-mentioned study, various other research groups have 
documented or suggested that in the hypoplastic lungs of CDH rats, immaturity of the 
lungs exists[12, 13,16]. Suen et al[13], using whole-lung homogenates, noted significantly 
lower desaturated phosphatidylcholine (DSPC) per microgram DNA and total DSPC in 
CDH rats, and Brandsma et al[16] using bronchoalveolar lavages of control and CDH 
rats, came to the same conclusion. Recently, Suen et al[17] documented the positive 
effect of antenatal glucocorticoid treatment on the DSPC content of whole lung 
homogenates in rats with Nitrofen-induced CDH. 
The reason we were not able to demonstrate a continuing positive effect on lung volume 
in CDH rats might be related to the method of delivery, dosage, timing, or volume of 
surfactant application; the effect of introducing PEEP should be determined as well. 
Human Data 
Increasing evidence shows that the hypoplastic lung in CDH is developmentally 
retarded[1-3]. A lower lecithin-sphingo myelin (LIS) ratio in the amniotic fluid' as well 
as morphological findings showing hyaline membranes in full-term infants with CDH 
emphasize the significance of a further characterization of the developing terminal lung 
unit in these patients. For a patient with CDH, accurate determination of the presence 
of a surfactant deficiency, either primary or secondary, will be of great significance in the 
selection of appropriate treatment modalities[18]. Moreover, the high incidence of 
bronchopulmonary dysplasia in surviving patients[19] might be prevented by early 
administration of surfactant, either prophylactically or therapeutically, as has been shown 
for premature infants with respiratory distress syndrome[20]. 
Treatment of CDH can be individualized by using standard procedures such as 
bronchoalveolar lavages, as documented by Stenmark et al[21] newborns with persistent 
pulmonary hypertension, to detect surfactant deficiency. Prospective randomized trials 
in CDH patients, using exogenous surfactant as either prophylaxis or rescue therapy, 
should be undertaken in the near future to test the value of this approach. 
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EFFECT OF ARTIFICIAL VENTILATION ON 
PULMONARY ANTIOXIDANT ENzyME ACTIVITIES 
IN A CONGENITAL DIAPHRAGMATIC HERNIA 
RAT MODEL 
(Adv Exp Med Bioi 1992; 317:363-70) 
INTRODUCTION 
Treatment of infants with congenital diaphragmatic hernia (CDR) developing respiratory 
insufficiency within a few hours after birth remains unsatisfactory. The incidence of CDR 
is about 1:3000 newborns (Razebroek et ai, 1988), mortality for these high-risk infants 
ranges from 30%-60%. These infants require aggressive respiratory support, including 
high pressures and oxygen concentrations. Frequently the clinical course is complicated 
by pulmonary hypertension. Compared to premature infants, CDR survivors have a high 
incidence (40%) of bronchopulmonary dysplasia (BPD) (Molenaar et ai, 1991; Redmond 
et ai, 1987; O'Rourke et ai, 1991). Because this disease occurs almost exclusively in 
premature infants who receive mechanical ventilation with increased inspiratory oxygen 
concentration, it was postulated (Northway et ai, 1967; Crapo, 1986) that oxygen alone 
is toxic to the lung parenchyma.Other factors that may play a role in BPD include 
gestational age, barotrauma, infection, the presence of a persistent ductus arteriosus 
(PDA), pulmonary hypertension and reperfusion damage. It is difficult to separate the 
effect of oxygen from those of other factors that may influence the development of BPD. 
Therefore the need for a reliable animal model (preferably with CDR) to study the 
pathogenesis of BPD and investigate protective measurements has augmented. DeLuca 
described barotrauma in ventilated CDR lambs; there was no specific mention of oxygen 
toxicity or its defense mechanisms (DeLuca et ai, 1987). 
The defense mechanism against oxygen damage has been extensively described (Tanswell 
and Freeman, 1984; Gerdin et ai, 1985; Frank and Sosenko, 1987a,b), but none of them 
deals with ventilated newborn animals. From the results of the cited 0, toxicity studies 
has evolved the concept that baseline antioxidative enzyme activity (AOA) levels are of 
much less importance in determining resistance or susceptibility to O,-induced lung 
damage than are the responses of the AOA to hyperoxic challenge. 
We are able to ventilate newborn rats with induced congenital diaphragmatic hernia 
(Tenbrinck et ai, 1990) and investigated the AOA levels in these CDR newborns in 
comparison with the data from similar treated control animals. 
This study consists of two experiments: the first to detect whether the development of 
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the baseline AOA levels in CDH rats differs from that of controls. We describe the 
developmental pattern of superoxide dismutase (CuZnSOD) (EC.l.15.l.1), catalase 
(EC.l.11.1.6) and glutathione peroxidase (GPX) (EC.l.1l.1.9) in the CDH lung during 
late gestation from day 19 up to birth. 
In the second experiment, animals were ventilated during 5 h with air or oxygen to 
establish different responses in AOA to hyperoxidative stress. 
MATERIALS AND METIIODS 
CDH was induced in pregnant Sprague Dawley rats by means of the herbicide nitrofen 
(Tenbrinck et ai, 1990). 1\vo groups of animals were studied: C = controls and N = 
nitrofen. In the N group animals were obtained with CDH = NH and without CDH = 
NN. The distinction between NN and NH groups could only be made after autopsy. 
In the first experiment, imaginable differences in late gestational development of AOA 
profiles were studied; in a second experiment the changes in AOA during 5 h ventilation 
with either air or 100% oxygen were observed. 
Animals 
In the first experiment, the fetuses were obtained by hysterotomy (days 19, 20, 21 of 
gestation) or after spontaneous birth at day 22 of gestation. After determination of 
bodyweight the fetuses were killed by an iotraperitoneal injection of pentobarbital (2 
g/kg) (Tenbrinck et ai, 1990). 
The thoracic cavity was opened, the presence of a possible diaphragmatic defect and its 
size noted; after this the lungs were perfused with phosphate buffered saline (PBS, 0.07 
mol/I, 4·C) via the pulmonary artery until they turned pale white. The perfused lungs 
were taken out, weighed, frozen in liquid nitrogen and stored at -70·C for biochemical 
assay. 
For the second experiment adult animals from groups C and N were allowed to deliver 
the pups after a gestation period of approximately 22 days. The pups were anesthetized 
(pentobarbital 35 mg/kg every 4 h), relaxed (pancuroniumbromide 0.1 mg/kg/h) and 
intubated. The tubes were connected with a body box (Lachmann, 1981) and the pups 
were ventilated with either FiO, = 0.21 or FiO, = 1.0 for 5 h to establish a possible 
difference in AOA during ventilation between C, NN and NH groups. The ventilator 
settings of the Servo 900B (Siemens Elema, Sweden) were the same throughout the 
experiment in C, NN and NH groups: pressure controlled 17/2 cm H,O; respiration rate 
40/min; I:E ratio 1:2. The animals were treated as in the first experiment after they had 
completed their 5 h ventilation period. 
Biochemical analysis 
After weighing, each obtained lung was coded and homogenized separately so no pools 
were made. In the homogenate we determined the protein (Lowry et ai, 1951) and DNA 
(Labarca et ai, 1980) content expressed per mg wet lung weight. For AOA estimation the 
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suspensions were centrifuged at 20,000 g for 30 min. The activity of the most prevailing 
SOD isoenzyme in the lung, the copper-zinc SOD (CuZnSOD) was assayed by the 
inhibition of xanthine xanthineoxidase catalyzed reduction of. ferricytochrome-c at pH 
10.2 in the presence of EDTA to chelate free copper; the unit of SOD activity was 
defined according to Fridovich. (Hayatdavoudi et aI, 1981; Biemond et aI, 1984). 
Catalase was measured as described earlier by Bergmeyer (Bergmeyer, 1955). 
Glutathione peroxidase (GPX) activity was assayed according to Paglia (Paglia et aI, 
1967). The activities of SOD, catalase and GPX were expressed as units per mg lung 
DNA to eliminate lung weight differences. 
Statistical analysis 
The data are presented as mean with one standard deviation (SD). After rank 
transformation treatment effects were evaluated by analysis of variance (Conover, 
1981).If a significant F-value was found, Bonferroni's correction method for multiple 
comparisons was used to identify differences among the groups (Glantz, 1987). A 
difference was considered statistically significant when the p-value was < 5%. No further 
indication of p-values are made; however lower values were found. 
RESULTS 
Wet lung weights increased in C, NN and NH groups during gestation (Table 1), but the 
mean lung weight of NN and NH was significantly lower compared to C. The differences 
between NN and NH were also significant. No significant differences between body 
weights were found. The L/B ratio was also significantly lower in tbe NH group before 
birth, suggesting that lung hypoplasia develops before birth. Lung protein and DNA 
content expressed per mg wet lung remained virtually unchanged in all groups; this is 
shown by the protein/DNA ratio which did not alter over time and amounted to a mean 
value of 7 for all groups. 
The CuZnSOD activity did not change significantly within the three groups between day 
19 to birth (Fig 1A). Catalase activity showed a significant increase in activity between 
day 21 and birth (Fig lB); however there was no significant difference between the 
groups. GPX activity (Fig Ie) increased in each group during gestation (time dependency 
in the three groups P< 0.001). The activity measured at birth for C, NN and NH was 
respectively 173%, 161% and 185% of the initial GPX activity at day 19 of gestation .. 
The effect of ventilation on AOA 
In tbe NH group only 2 animals survived the 5 h ventilation period with Fi02 = 0.21, the 
others died within a few hours after start of ventilation. Therefore it was decided to use 
data of animals immediately after birth as reference values rather than those who were 
not ventilated for 5 h, because none of the NH animals survived the 5 h without 
ventilation. There were no significant differences in lung weight, body weight, L/B ratio, 
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Table 1. Late gestational changes (day 19 until birth) in groups C, NN. NH in several lung parameters. I~ LW BW LIB ratio DNA protein PID ratio 
mg g mg/g ~g/mg LW ~g/mg LW 
19 43 (7) LSI (0.15) 282 (2.4) 10.4 (0.7) 71.5 (4.3) 6.9 (0.1) 
C 20 90 (5) 2.73 (0.3) 33.8 (1.7) 82 (1.4) 71.1 (4.7) 9.0 (1.8) 
21 122 (8) 3.90 (0.01) 335 (0.9) 9.6 (0.7) 62.8 (3.9) 6.6 (0.7) 
birth 136 (21) 5.43 (0.32) 28.1 (2.6) 10.3 (LJ) 64.1 (7.8) 65 (0.8) I~ 
19 41 (4) 157 (0.14) 25.8 (1.6) 11.0 (05) 72.7 (4.3) 6.6 (0.1) 
NN 20 66 (5) # 255 (0.45) 27.1 (1.8) 8.9 (1.4) 61.7 (62) 7.2 (0.8) 
21 137 (12) 4.49 (0.42) 30.8 (1.1) 75 (12) 59.8 (6.3) 8.3 (2.0) 
birth 109 (6) # 5.08 (0.07) 22.6 (1.2) 8.8 (05) 65.0 (6.8) 7.4 (0.8) 
19 35 (5) # 1.45 (0.14) 24.1 (1.8) # 11.2 (1.0) 76.9 (3.7) 6.7 (0.1) 
NH 20 47 (18) #' 1.98 (0.73) 26.6 (2.7) # 9.7 (1.1) 65.2 (6.7) 6.7 (0.1) 
21 99 (17) #' 4.21 (0.72) 24.8 (5.1) #' 9.2 (0.8) 63.4 (35) 7.0 (0.9) 
birth 63 (10) #' 4.96 (0.44) 12.2 (2.1) #' 12.1 (1.6) 83.4 (11.3) 7.0 (0.1) 
Abbreviations: values are expressed as mean.±. (standard deviation); each parameter is assessed in 6 animals. LW lungweight~ 
BW body weight; LIB ratio lung weight/ body weight; PID ratio protein content/ DNA content. # significant (p<O.05) from C; 
.. significant (p < 0.05) from NN. 
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DNA, protein and P /D ratio between the ventilated animals and their initial values 
immediately after birth. The existing differences between the groups remained the same. 
Table 2 shows that in the C and NN groups the values for CuZnSOD, Catalase and GPX 
did not change significantly under the influence of ventilation, neither with air nor with 
100% oxygen. 
In the NH group CuZnSOD showed a tendency to decrease under both ventilatory 
conditions to about 85% of initial activity (P=0.18 for NH 100% oxygen). This value was 
significant from the same value in the C and NN groups. Catalase activity in the NH rats 
remained at the initial level and was similar to values in the C and NN groups. 
Values for GPX activity decreased significantly to 78% and even 68% of initial values 
after ventilation with room air or 100% oxygen, respectively. Also compared to the C 
100% value. this means a significant decrease of 21 %. 
Table 2. The effect of ventilation with either air or 100% oxygen on SOD, catalase and 
GPX activities in the three groups (C, NN, NH). 
n SOD Catalase GPX 
(U/mg DNA) (IU/mg DNA) (mUfmg DNA) 
birth 10 22.1 (2.2) 142 (27) 277 (4ll) 
C air 7 W.9 (3.5) 136 (23) 276 (19) 
100% 8 22.8 (4.5) 126 (14) 271 (41) 
birth 7 19.4 (4.4) 146 (30) 283 (44) 
NN air 6 24.5 (4.6) 117 (12) 264 (12) 
100% 9 24.6 (5.1) 144 (31) 255 (41) 
birth 7 W.7 (4.7) 124 (30) 315 (45)# 
NH air 2 17.5 (0.2) 119 (10) 246 (12) 
100% 6 17.9 (1.2)# 134 (4ll) 216 (24)'# 
Values are expressed as mean ±. (SD), * significant (p<5%) from birth value in the same group, # 
significant (p<5%) from controls. 
DISCUSSION 
CDH lungs are hypoplastic in humans (Areechon, 1963), as well as in the rat model 
(Tenbrinck, 1990) this is mainly based on morphological differences, however little is 
known about the biochemical compound of the hypoplastic lung. Frank reported that 
in the rat the chronology of development of AOA is very similar to that of the fetal 
surfactant system (Frank, 1987a). A different content of lecithin-sphingomyelin in 
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amniotic fluid of fetuses with hypoplastic lungs has been found (Hisanaga, 1984). 
CDH lungs of humans (Redmond, 1987) and fetal lambs (DeLuca et ai, 1987) are very 
vulnerable to high inflation pressures. Nothing is known about their reaction to high 
inspiratory oxygen concentrations during ventilation. In healthy lungs the AOA levels 
are strongly correlated with the degree of protection that may be anticipated from 0, 
radical induced lung injury. Increased enzyme activity has been consistently found in 
association with tolerance to hyperoxia, and reduced AOA usually leads to greater than 
normal susceptibility of the lung to high 0, concentrations. This phenomenon was 
recently demonstrated in healthy premature rabbits compared with term rabbits (Frank 
and Sosenko, 1991). Literature search revealed no study in which the effect of 
ventilation on AOA in newborn CDH vs healthy (rat) lungs was described. 
In the first experiment of this study we concluded that baseline AOA levels are almost 
the same throughout the three groups. We also found a similar developmental pattern 
in late gestation. These results are in accordance with those found by others (Frank 
and Sosenko, 1987a; Tanswell, 1984; Gerdin et aI, 1985; Hayashibe et ai, 1990). The 
lung weights in the NH group were lower than that in C and NN so the total amount 
of AOA is reduced. This indicates that the CDH lungs does not differ qualitatively 
from the C and NN lungs, but only quantitatively. This is also supported by the 
unchanged protein/DNA ratio in the groups. 
In the second experiment we concluded that in the NH group the SOD and GPX 
activities tended to decrease during ventilation both with room air and oxygen. This 
supports our hypothesis that the CDH lung behaves like a premature lung and unlike 
C and NN lungs, would fail to mount a protective increase in AOA during ventilation 
with high FiO,. This failure could be an explanation for the increased susceptibility to 
O,-induced damage in CDH lungs. 
Because the NH FiO, = 0.21 group consisted of only 2 surviving animals, care has to 
be taken with the interpretation of these results. Also in the larger NH FiO, = 1.0 
group care has to be taken with simplification that the decreased SOD and GPX levels 
alone are the cause of the high incidence of BPD in human CDH survivors. On the 
basis of these experiments we could only speculate about the consequences of our 
results for the clinical practice. Of more importance is that this is the first applicable 
in vivo study that deals with the problem of oxygen toxicity in hypoplastic CDH lungs 
during ventilation. 
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EPILOGUE 
10.1 General 
Neonates with congenital diaphragmatic hernia (CDH) experience a high mortality 
despite intensive medical and surgical treatment. 111is mortality is caused by a 
combination of pulmonary hypoplasia and pubnonary hypertension [1·4]. Clinical and 
postmortem reports show that CDH lungs resemble the immature lungs of premature 
newborns; they lack adequate surfactant, have poor compliance and demonstrate 
immature morphology; hyaline membrane formation is also observed [4·8]. 
Efforts were made to apply scoring systems [9] for the prediction of CDH severity. The 
implementation of new techniques such as high frequency ventilation, extracorporeal 
membranous oxygenation, and a variety of vasoactive drugs did not affect the mortality 
as was expected [3,4,10]. Over the years it became clear that the basic problem in CDH 
treatment is a substantial lack of knowledge of the developmental process leading to 
CDH. The translation of the encountered problems into an animal model can yield new 
ideas, or even enable to find more specific modes of treatment. 
Until now two types of animal models concerning CDH exist: Surgically induced CDH 
in e.g. sheep [11], and a nitrofen-induced CDH model in rats (12]. 
10.2 Surgically induced CDH 
Various animals are used for surgical induction of CDH; the lamb is the most 
widespread used [11,13,14], but also monkeys [15] and rabbits [16] have been tested. 
The timing of CDH induction in lambs is, as in rats, important; the earlier in fetal life 
the lesion is produced the more severe the hypoplasia (14]. Because it is based on 
penetration of a balloon [17] or bowels [11,18] through an already closed diaphragm 
there is a limit in the advancing of the operation time; Adzick et al. created CDH in 
lambs at gestational day 60-63 [19]. The CDH lamb is surfactant deficient [20]. In the 
lamb it is possible to evaluate hemodynamics and the influence of ventilation on blood-
gas values and morphology [14,18-20]. Recently Wilcox et al. [21] reported on the effect 
of exogenous surfactant replacement therapy on gas exchange; both lung mechanics and 
gas exchange were markedly improved. 
Harrison's group used the lamb model to study pubnonary hypoplasia that accompanies 
CDH and the possibility of reversing these changes by correcting the diaphragmatic 
defect in utero. Fetal therapy is the logical culmination of progress in fetal diagnosis. In 
other words, the fetus is now a patient [22,23]. This influenced the ideas of Harrison's 
group on the embryological aspects of CDH: pulmonary hypoplasia was caused by 
migrated bowels during fetal development and could be corrected by retracting these 
loops out of the thoracic cavity in an as early as possible stage of development. The lungs 
will show a compensatory growth which \vill beneficially influence survival. The results 
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of the animal experiments conducted by Harrison et al. proved, at least partially, their 
ideas. 
Pulmonary hypoplasia in humans can also be associated with other anomalies such as 
renal dysplasia [24] and oligohydramnios [24,25]. Animal experiments in sheep revealed 
a relation between pulmonary fluid dynamics and pulmonary growth [26,27,28]. Tracheal 
ligation in the fetus accelerates lung growth beyond normal limits, even in the absence 
of kidneys [29,30,31]. One of the members of Harrison's group, Hedrick [32] ligated the 
trachea of CDH lambs during fetal development, which resulted in an improved survival 
of the lamb with CDH after birth. This plugging is considered to provide a less invasive 
way of intra-uterine CDH treatment. Wallen et al. [33] showed that fetal surgery sham 
operation had an adverse effect on lung growth: there was a significant decrease in DNA, 
protein and saturated phosphatidylcholine, but no significant change in lung volume was 
observed. 
10.3 Nitrofen induced CDH 
The results of research using this model are extensively described in the preceding 
chapters. The main conclusions are: 
CDH can be successfully induced in large numbers of rats by means of a single dose 
nitro fen in an early stage of development [12]. The CDH lungs are hypoplastic 
considering lung weight and radial saccular count, and are affected equally comparing 
the left-right lung weight ratio [12J. 
Pulmonary vascular changes in CDH rats [34] strongly resemble the human pathology 
[35]: At the level of the respiratory bronchioles the pulmonary arteries in CDH lungs 
show decreased external diameter and increased wall thickness as percentage of the 
external thickness; this is due to hyperplasia of the muscular coating [34]. 
The early induction of CDH makes this model suitable for further embryological studies 
[36]. The first discovery was that the day of nitrofen exposure is important: left-sided 
congenital diaphragmatic hernia was only observed on day 9 exposure. When nitrofen 
was given on day 10-12 only right-sided CDH was observed [36]. It also appeared that 
the pleuroperitoneal openings are not the precursors of the diaphragmatic defect [37]. 
The rat model can he used to evaluate the biochemical and histological differences in 
CDH; because the rats can be ventilated for a limited time [38] it also enables to 
investigate the effect of pre or postnatal administered drugs on postnatal lung function 
[39-41]. 
10.4 Hormonal influence on prenatal lung development in rats 
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Antenatal maternal glucocorticoid therapy is known to accelerate pulmonary 
development in premature, otherwise healthy neonates, and has a decreased incidence 
of respiratory distress syndrome and pulmonary complications of preterm neonates of 
different species [41,42J. Biochemical evidence is found of increased surfactant 
production [43J, and increased antioxidant enzyme activities in fetal lung [44J. Functional 
the treated lungs show increased maximal lung volume and compliance [45J. 
Several investigations indicate the benefit of antenatal hormone administration in CDH 
rats. 
Biochemically the CDH lungs in rats are inunature or hypoplastic with regard to DNA 
[38,39J, phospholipid [39,46J, and antioxidant enzyme activity [38J. Also morphologic 
measurements show hypoplasia: lowered lung weight, volumes and RSC [12J or 
inunaturity evidenced by a retarded differentiation of cuboid type II cells into squamous 
type I cells [47J. 
Suen et al. [48J administered antenatal dexamethasone to nitrofen treated rats and 
observed increased disaturated phosphatidylcholine content, reduced lung glycogen, 
reduced saccular septal thickness and increased mean saccular size in rats with severe 
CDR. 
Thyroid hormone acts synergistically with glucocorticoid in stimulating the synthesis of 
phosphatidylcholine [49,50J. The thyroid hormone is given as thyrotropin.releasing 
hormone (TRH) which crosses the placenta and increases thyrotropin (TSH), T3, T4 and 
prolactin concentrations in preterm fetuses [51J. 
This combined therapy was used in CDH rats [52J; the expected synergism was found to 
a significant extent. 
10.5 Differences between "rat" and "lamb" CDH 
Both models have their own (dis)advantages; it depends on the question posed as to 
which model is the most suitable. Table 10.1 shows some characteristics of both models. 
Rats are easily obtainable in large numbers; even with an unforeseen large failure 
percentage this will lead to a minimal delay in experiments. The low weight of the rats, 
with the recent advancement in biochemical techniques, is hardly a disadvantage. 
Hemodynamic measurements and the taking of blood samples from rat neonates is 
unfortunately impossible, as is probably fetal surgery. 
epilogue 107 
Table 10.1 Characteristics of CDH in rats versus lambs 
Rat model Lamb model 
number control ++ 
number CDH ++ 
embryological study + 
fetal study + + 
neonatal study + + 
pre-partum drugs administration + + 
post-partum drugs administration + + 
biochemical characterization + + 
fetal surgery -? ++ 
artificial ventilation + + 
hemodynamics / blood gas measurements ++ 
cost-effective ++ 
Concerning the properties of the model + = suitable; - = not suitable. 
10.6 Consequences of animal models for the human situation 
Because Harrison et aJ. considered the fetus with congenital malformations as a patient 
[22] and their experiments performing fetal surgery in lambs and monkeys were 
promising, the operation of human fetuses was a more or less logical step. The mortality 
rate in the first CDH population (n =83; operation at 24 weeks gestation) was about 58% 
[53]. Improved, less invasive videofetoscopic techniques [54] will simplify the surgical 
approach to CDH and the PLUG (Plug the Lung Until it Grows) method will be the first 
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method of choice [23J. 
The use of BCMO in CDR treatment is common (provided it is available); it provides 
a temporary period of rest for the lung, but problems in the post-BCMO period due to 
artificial ventilation or supplementary oxygen leading to BPD may result in postponed 
death in a number of patients [55J. 
Surfactant replacement improves blood gases and pulmonary dyoamics [56,57J; trials have 
yet to reveal the effects on BPD prevention. The use of antioxidative enzymes would 
decrease the rate of BPD, but until now there is no adequate way to bring these enzymes 
intracellular for optimal effect [38,58J. 
The changes in the pulmonary arterial bed, causing pulmonary hypertension in CDR, are 
often therapy resistant. Many vasoactive drugs have been used, but none of them 
appeared to represent a breakthrough [4J. The combination of BCMO and the use of 
tracheal administered nitric oxide is proving beneficial in the modulation of pulmonary 
vascular tone. But, often, there is a rebound effect after withdrawal [59J. 
CDR research in future needs to evaluate the effects of hormonal therapy. The work will 
involve the investigation for specific receptor-expression and their role during 
organogenesis and fetal development. If these specific receptors are found, more effective 
drugs can be developed to more effectively stimulate preterm lung growth. 
The translation and implementation of these new drugs in the human situation will take 
several years; to bridge this time, combined prenatal hormonal therapy (TRR plus 
glucocorticoids) and surfactant replacement therapy, BCMO and nitric oxide postnatal 
are the tools of choice; perhaps antioxidative drugs will be added to this list in the 
coming years. 
The role of fetal surgery will probably remain limited, due to the ethical aspects 
involved. 
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SUMMARY 
Neonates with congenital diaphragmatic hernia(CDH) experience a high mortality 
despite intensive medical and surgical treatment. The estimated incidence is 1:3000 
newborns. The basic anomaly is a defect of the diaphragm left or right sided; this defect 
can be treated relative easily by pediatric surgeons. 
However it is the associated pulmonary hypoplasia, often accompanied by well 
documented abnormalities in the pulmonary vessels, that gives tremendous pre and post 
operative problems. CDH mortality has not dropped in contrast to that of other 
congenital anomalies; it still remains between 30·60%.In surviving patients there is a high 
morbidity consisting of bronchopulmonary dysplasia(BPD) and gastro·esophageal reflux. 
In order to obtain more basic information on CDH and its puhnonary malformations, 
it was recognized early that CDH research should be performed in animal models. The 
lamb model, introduced in 1967 by deLorimer, did not reveal much about the real cause 
of pulmonary hypoplasia. 
Because of the disadvantage of the lamb model, this study was initiated with the 
objective to set up an CDH model in rats where CDH was introduced by a herbicide 
(nitrofen) in an early stage of embryological development. Investigation of the processes 
from this early stage of development to birth may reveal new perspectives in CDH 
research and subsequent treatment. 
Chapter 1 is the introduction to the subject of this thesis and presents the aims of the 
different experiments. 
Chapter 2 gives a review of the literature concerning the various suhjects involved in 
CDH research. 
The model is introduced in chapter 3. Nitrofen (2,4.dichlorophenyl-p·nitrophenyl ether) 
can induce anatomical malformations in rats including congenital diaphragmatic hernia. 
On day 10 of gestation (total gestation 22 days) 115mg/kg body weight nitrofen dissolved 
in olive oil, was administered to the pregnant rats by means of a gastric tube. This leads 
to a high incidence -up to 60%- of right sided CDH and subsequent pulmonary 
hypoplasia in the rat neonates, comparable to the human situation. Both the lung weight/ 
body weight index as well as the radial saccular count (both generally accepted indices 
of pulmonary development) were significantly lower in the animals with CDH. 
In chapter 4 we investigated both the effect of changing the day of gestation (9th to 13th 
day) to give a single dose of nitrofen as well as the effect of different dosages (50, 100, 
150 mg/kg bw). The results were: 1] most hernias occurred after administration of 100 
mg nitrofen on day 9 (42%) and 11 (59%); 2]left-sided CDH were observed only after 
exposure to nitro fen on day 9; 3] after exposure on day 10 or later all hernias were on 
the right side. The outcome in chapter 3 and 4 shows that the model is suitable for 
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further study of abnormal lung development in relation to ventilatory capacity and 
pulmonary vascular reactivity. 
Chapter 5 is a histological evaluation of the pulmonary vascular abnormalities 
encountered in CDH rats. We examined the newborn rats after perfusion of the 
pulmonary arteries with barium gelatine and subsequent fixation. At the level of the 
respiratory bronchioles significant differences in the vessels were found, consisting of 
decreased external diameter and increased wall thickness as percentage of the external 
thickness in CDH lung compared to controls. Abnormal muscularisation of the 
peripheral branches of the CDH pulmonary arteries was also found. With respect to the 
pulmonary vasculature the rat model strongly resembles the human situation 
Chapter 6 is a further description of the developmental aspects of the CDH lung. Up to 
now, descriptions of the natural history of CDH and pulmonary hypoplasia are based 
exclusively on observations made in the fetal period. However nothing is known about 
the events that take place in the embryo with CDH. 
The abnormal development of the diaphragm was first seen in embryos aged 13 to 14 
days. A defect appeared in the dorsal part of the diaphragm, normally on the right 
side(nitrofen was given on day 11 of gestation). The liver grew through this defect early 
on. The gut was found intrathoracic in late stages (day 21-22 gestation) and newborns. 
Most authors speculate that CDH results because the pleuroperitoneal canals fail to 
close at the end of the embryonic period (ie, week 8 to 10 in human development) 
leading to a defect in the dorsolateral region of the diaphragm. However our findings 
indicate that diaphragmatic defects develop in early embryonic life. They are easy to 
identify in rat embryos as early as 14 days. During development the expansion of the 
thoracic cavity is obvious, so the lung still continuous to grow, while part of the chest is 
occupied by liver. In a growing embryonic body, compression is uniikely; the growth 
impairment is rather the result of growth competition in the embryo: the liver that grows 
faster than the lung reduces the available thoracic space. 
The research in Chapter 7 adds an important factor to the model: newborn rats (Control, 
CDH and Nitrofen) can be ventilated for several hours. The spontaneous born rats were 
anesthetized and intubated, and ventilated in a heated multichambered box. The 
ventilatory settings were: FiO, = 1; Inspiratory peak pressure 17 em H,O, with positive 
end expiratory pressure 0 em H,o; frequency 40/min; Inspiratory/expiratory ratio is 1/2. 
The control and nitrofen treated animals were ventilated for 6 hours without much 
problems, but in the CDH group about 80% of the severe CDH died within this period. 
By registration of the changing pressures and their matching volumes, we created 
individual inflation and deflation curves at a distinct time (0, 1, 6 hours). The individual 
deflation curves of the three groups were compared and analyzed statistically. 
The measured pressure: volume registrations showed low compliance values without 
improvement during time in the CDH group. This suggests an involvement of the 
summary 114 
surfactant system. 
Chapter 8 describes the effect of surfactant instillation on the pressure-volume 
registrations. Surfactant application had a positive effect on lung volume,especially in 
control rats after 1 hour ventilation. No significant differences were observed between 
the CDR groups after 1 and 6 hours ventilation. A continued positive effect on lung 
volume could not be determined. 
The first study about the effects of the ventilation on antioxidative enzyme activity 
(AOA) is showed in Chapter 9. Compared to mature infants, CDR survivors have a high 
incidence (40%) of bronchopulmonary dysplasia (BPD), a similar percentage is also 
found in prematures. One of the presumed causes of this serious disease is a oxygen 
radical Induced damage of the lungs during longer periods of raised inspiratory oxygen 
concentrations. The primary defense against radical induced damage are the AOA; 
during radical challenge the AOA has to go up. In our experiment we found a not 
significant (in the short 6 hour study period) trend of decreasing AOA. These results are 
to fragile to speculate about clinical significance, but further research migbt bring more 
definite results. 
Chapter 10. compares the rat model and the lamb model; both models have their own 
field of optimal application. Using both research models will perhaps lead to results that 
can decrease mortality and morbidity of CDR. 
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SAMENVATIING 
Dit proefschrift beschrijft de ontwikkeling van een diermodel met de kenmerken en 
symptomen van congenitale hernia diafragmatica (CHD). Congenitale hernia 
diafragmatica komt voor bij 1 : 3-5000 pasgeborenen. Het is een aangeboren afwijking 
waarbij de buikorganen via een defect in het middenrif in de borstholte hernieren. Het 
defect kan betrekkelijk gemakkelijk worden geopereerd door kinderchirurgen. De 
bijbehorende longhypoplasie, vaak vergezeld van afwijkingen in het pulmonale 
vaatstelsel, geven pre- en postoperatief grote problemen. In tegenstelling tot andere 
aangeboren afwijkingen is de mortaliteit van CHD nauwelijks gedaald. AI jareniang ligt 
dit percentage lussen de 30 en 60%. In overlevende patienten wordt een hoge incidentie 
van broncho-pulmonale dysplasie (BPD) gevonden. Deze longaandoening komt anders 
eigenlijk aileen voor bij te vroeg geborenen. 
am inzicht te krijgen in de pulmonale afwijkingen bij CHD werd duidelijk dat het 
onderzoek gebruik zou moeten maken van diermodellen. In 1967 introduceerde 
deLorimer een model in schapen. Dit gaf echter geen duidelijke iuformatie over het 
ontstaan van de longhypoplasie. Bij de rat kan CHD worden gelnduceerd door in een 
vroeg stadium van de embryonale ontwikkeling het herbicide nitro fen aan de zwangere 
moeder toe te dienen. Onderzoek van de orgaanontwikkeling, in de periode van de vroeg 
embryonale ontwikkeling tot de geboorte, kan perspectieven bieden in het CHD 
onderzoek, met mogelijke gevolgen voor behandeling. 
In hoordsluk 1 wordt het probleem van CHD en longhypoplasie gelntroduceerd. Het 
beval tevens de doelstellingen van de verschillende experimenten. 
Hoordsluk 2 geeft een overzicht van de bestaande literaluur, die betrekking heeft op de 
verschillende onderwerpen in het CHD onderzoek. 
Het rattenmodel van CHD wordt gemtroduceerd in hoordsluk 3. Nitrofen (2.4-
dichlorophenyl-p-nitrophenyl ether) kan verschillende anatomische afwijkingen induceren 
bij de rat, waaronder congenitale hernia diafragmatica. Op dag 10 van de zwangerschap 
(totale zwangerschapduur 22 dagen) wordt 115 mg/kg lichaamsgewicht nitrofen opgelost 
in olijfolie en oraal aan de zwangere ratten toegediend. Dit leidt uiteindelijk tot een 
hoge incidentie - tot 60% - van rechtszijdige CHD in de pasgeboren ratten. Zowel de 
long-/lichaamsgewichtindex als de radial saccular count (beide in de literatuur 
geaccepteerde indicatoren voor pulmonale ontwikkeling) zijn significant lager in de 
dieren met CHD. Deze situatie lijkt sterk op die bij de mens. 
In hoordsluk 4 hebben wij het effect onderzocht van verandering van het tijdstip van de 
nitrofengift (9 tot 13 dagen), alsmede het effect van verschillende doseringen (50, 100 
en 150 mg/kg lichaamsgewicht). Dit resulteerde in de volgende bevindingen: lJ de 
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meeste hernia's werden gevonden bij een dosering van 100 mg/kg nitrofen op dag 9 en 
11; 2]linkszijdige hernia's werden alleen gevonden na toediening van nitrofen op dag 9; 
3] na toediening op dag 10 of later werden uitsluitend rechtszijdige hernia's gevonden. 
De conclusie van hoofdstuk 3 en 4 is dat het model geschikt is voor verdere stu die van 
abnormale longontwikkeling. 
Hoofdstuk 5 is een histologische evaluatie van de pulmonale vaatafwijkingen die worden 
gevonden in de CHD-ratten. Het pulmonale vaatbed van de pasgeboren ratten werd 
geperfundeerd met een barium gelatine oplossing en daarna in-situ gefixeerd; bij de 
CHD-ratten werden significante verschillen gevonden in de vaatstructuren op het niveau 
van de respiratoire bronchiolen. Het betrof hier een kleinere externe diameter met een 
toegenomen wanddikte als percentage van de externe dikte. Tevens werden abnormale 
muscularisatie van de perifere pulmonale arteries gevonden; de pulmonale vaten in de 
rat leken sterk op de humane situatie. 
Hoofdstuk 6 beschrijft een aantal ontwikkelingsaspecten van de CHD-Iong. Tot nu toe 
zijn de beschrijvingen van de ontwikkelingen van CHD met longhypoplasie eigenlijk 
uitsluitend gebaseerd op waarnemingen die in de foetale periode gedaan zijn. Er is niets 
bekend over de ontwikkelingen die in de embryonale fase plaatsvinden. De abnormale 
ontwikkeling van het middenrif( diafragma) werd het eerst gezien in embryo's van 13 tot 
14 dagen oud. Het defect verscheen in het dorsale gedeelte van het middenrif, meestal 
aan de rechterzijde (nitrofen werd op dag 11 gegeven). De lever groeide door dit defect 
heen, dit was al in een vroeg stadium ziehtbaar. Darm werd pas in een later stadium 
intrathoracaal gevonden (dag 21 tot 22). Deze studie toonde aan dat het defect in het 
middenrif in een vroeg stadium van de embryonale ontwikkeling ontstaat. Het defect kan 
worden gevonden bij ratte-embryo's vanaf 14 dagen. Tijdens de ontwikkeling blijft er een 
duidelijke groei van de thoracale holte, zodat ook de long blijft groeien. Echter, een deel 
van de borstholte wordt ingenomen door de lever. Het idee van compressie van de long 
door lever of darm in een groeiend lichaam is daardoor onwaarschijnlijk; de 
groeibelemmering is waarschijn1ijk meer te wijten aan een competitie in het groeiende 
embryo: de lever groeit sneller dan de long en reduceert daardoor de beschikbare plaats 
in de thoracale holte. 
Het onderzoek besehreven in hoordstuk 7 voegt een belangrijke factor toe aan het 
model: pasgeboren ratten kunnen worden beademd gedurende een aantal uren. Spontaan 
geboren ratten krijgen algehele anaesthesie met intubatie en beademing in een 
verwarmde meerkamer box. De ventilator ins telling is als voIgt: Fi02 = 1; Inspiratoire 
piekdruk 17 cm H,o, met een PEEP = 0 em H20; frequentie 40/min; I/E ratio 1/2. De 
controlegroep en de met nitrofen behandelde dieren worden beademd gedurende 6 uur. 
In de herniagroep sterft rond de 80% in deze periode. Van de individuele ratten worden 
de beademingsdrukken en de bijbehorende volumes geregisteerd op de tijdstippen 0, 1 
en 6 uur. De aldus verkregen inspiratoire en expiratoire curves worden vergeleken en 
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statistisch geanalyseerd. De CHD-groep heeft een lage compliantie met weinig 
verbetering gedurende de beademingsperiode. Dit kan duiden op een betrokkenheid van 
het surfactant-systeem. 
Hoofdstuk 8 bescbrijft de effecten van het toedienen van surfactant op de druk-volume 
curves. Surfactant toediening had een positief effect op het longvolume, vooral in de 
controle ratten na 1 uur ventilatie. Er werden geen significante verschillen gevonden 
tussen de CHD-groepen, na 1 en 6 uur beademen. Een blijvend posWef effect op het 
longvolume kon niet worden aangetoond. 
De eerste stu die over de effecten van ventilatie op de antioxidatieve enzymactiviteit 
(AOA) is omschreven in hoofdstuk 9. In vergelijking met it terme geboren kinderen 
hebben CHD-overlevenden een hoge incidentie (40%) van bronchopulmonale dysplasie. 
Dit percentage is ongeveer gelijk aan dat wat in prematuren gevonden word. In dit 
experiment vonden \Vij een niet-significante trend van een dalende AOA. Deze resultaten 
zijn te mager om te speculeren over een eventuele klinische relevantie. Verder 
onderzoek in deze richting zou misschien betere resultaten kunnen opleveren. 
Hoofstuk 10 vergelijkt het rattemodel en bet lamsmodel; beide modellen bebben een 
eigen toepassingsgebied. Gebruik van beide modellen zou uiteindelijk tot resultaten 
kunnen leiden die effect hebben op de mortaliteit en morbiditeit van de CHD. 
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werd mij in 1988 door Dr. D. Tibboel gevraagd om een diermodel in ratten op te zetten 
met de kenmerken van CHD. Gedurende de ruim twee jaar dat ik als medewerker van 
de afdeling kinderchirurgie hieraan kon werken, alsmede in de periode hierna, heb ik 
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experimentele anaesthesie. Deze periode, voorafgaand aan het CHD·onderzoek, bleek 
een goede basis. Dat u als promotor wil optreden verheugt mij dan ook zeer. 
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onder handbereik, altijd bereid te adviseren/controleren van de body-box met meetgereL 
Laraine Visser_ Thenk you very much, my englisch improfed a lot during these years, but 
I dare not sent a letter away without your magic eye. 
Biochemisch gezien veel dank aan Dr. W Sluiter en de gastvrijheid van zijn lab: Regina 
en Alfredo hebben een duidelijke inbreng gehad bij het bewerken van de longen voor 
de antioxidatieve enzym activiteit bepalingen. Wim, nu wordt het tijd om de biochemie 
van het Belgische bier eens te bestuderen, in plaats van de etiketten. 
Dr. D. Kluth. Dietrich, die Zusammenarbeit war ziemlich erfolgreich. Es freudt mich 
sehr dass dU,auch am 31 Mai dabei sein sollst. Auch Dank rur Marianne, wegen der sehr 
freurdichen Empfang in Norderstedt wiihrend meine Besuchen an Hamburg. 
Prof. Dr. W. Lambrecht und Dr. P. Reich. Auch Ihnen mochte ich bedanken; die beste 
Miindelhornchen kauft man in Eutin wiihrend die Pestspiele; Biiume in Hamburg sind 
besser gesiitzlich geschlitzt wie in Holland. 
De opvolgers van het onderzoek: Attie (dit onderzoek is een goede voorbereiding op 
gynecologie want een bevalling om 4 uur 's nachts is het moDiste dat er is: deze ratten 
bevallen toch altijd tussen 3 en 6 uur?); Elke (waarom worden ze niet zwanger?); 
Hanneke (ik doe een sectio want dan vallen er minder dieren uit het protocol; bovendien 
is dat een goede voorbereiding op kindergeneeskunde). Kortom ieder heeft op haar 
eigen wijze de tolerantie drempel verhoogd. 
Annelies Brandsma. De evemvijdige onderzoekskoers bracht heel andere problemen, 
maar uiteindelijk werd toch de haven bereikt. 
De heren portiers van faculteit (ik moet even naar het lab; past deze ladder ook in de 
lift?) en van het SKZ (de correspondentie met prof. Tibboel). 
Ook de medewerkers van het Chirurgisch Laboratorium worden bedankt voor de hulp: 
Pim en Lidia voor de analyses, Kas voor de beestjes. 
Dr. C. Moreley, Colin thank you for your hospitality in Cambridge and the facilities and 
expertise of your laboratry on phospholipid chemistry. 
Annemarie voor het kontakt tussen mij(onbereikbaar) en Dick(altijd weg). 
Sharida, Amina en Janine bedankt voor de secretariele werkzaamheden en de briefjes 
in mijn postvak. 
Mensen van de experimentele anaesthesie: Govinda, Diederik, Annemarie en Pneu, 
Serge, Edwin, Erwin(2x), Stephan, Arthur en uit de oude doos ook nog Siggi, Wolfgang, 
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Jelle, Erik, Geert Jan en Frits(halothaan) Smit. Altijd bereid problemen op te lossen of 
de helpende hand toe te steken, bedankt. 
Andere "medestrijders" Leon, Freek, Arthur, Johan. 
Jelle Bos; uitzicht op zee neem je wei zeer letterlijk, maar ik hoop dat je ook nog eens 
de diepte in kan gaan. Ik zal de "snij-sessies" met jou en Erik Eijking boven (in?) 
Sorbonne niet licht vergeten. Erik E., collega/vriend het leven is meer dan een video en 
Melief. 
Geert Jan en Olav, paranymfen, wij kennen elkaar al zo lang dat woorden tekort zullen 
schieten. Zeilen, roeien, onderzoeker van het eerste uur, directeur. 
Mijn opleider Prof. Dr. W. Erdmann dank ik voor het beoordelen van rnijn manuscript 
als secretaris van de promotiecomrnissie. 
De verpleegkundigen, stafleden en assistenten van de afdeling anaesthesiologie van het 
AZR, dank ik voor de steun cq belangstelling gedurende de jaren. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 21 juli 1960 te Vlaardingen. In 1980 
behaalde hij het diploma Atheneum aan de scholengemeenschap "Ring van Putten" te 
Spijkenisse. De studie geneeskunde aan de Erasmus Universiteit te Rotterdam werd in 
1981, een jaar na aanvang, onderbroken voor de rnilitaire dienst. 
De studie geneeskunde werd in 1982 voortgezet; het doctoraalexamen werd in februari 
1988 behaald. Gedurende zijn studie vervulde hij een student-assistentschap bij Prof. Dr. 
B. Lachmann op de afdeling Experimentele Anaesthesiologie van de Erasmus 
Universiteit. Na zijn doctoraal examen trad hij in dienst als wetenschappelijk 
medewerker bij de afdeling Kinderchirurgie van het Sophia Kinderziekenhuis (hoofd 
Prof. Dr. J.G Molenaar). In een samenwerkings verband tussenKinderchirurgie(Prof. Dr. 
D. Tibboel), Experimentele Anaesthesiologie (Prof. Dr. B. Lachmann) en Stichting voor 
Cytodiagnostiek (Dr. J.L.J. Gaillard) werd een model in ratten ontwikkeld met de 
kemnerken van congenitale hernia diaphragmatica. Spoedig werd ook samengewerkt met 
de afdeling "Kinderchirurgie van Universitiits Klinik Eppendorf' te Hamburg, Duitsland 
(Prof. Dr. W. Lambrecht en Dr. D. Kluth). 
In 1991 werd de artsenopleiding afgerond. In november 1991 kwam hij in diens! van de 
afdeling Anesthesiologie (hoofd Prof. Dr. W. Erdmann) van het Academisch Ziekenhuis 
Dijkzigt. 
Vanaf 1988 tot heden werd gewerkt aan de uitbreiding van het diermodel dat de basis 
vormt voor dit proefschrift. 
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